{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32148647", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "19"}, "DateRevised": {"Year": "2020", "Month": "10", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "02", "Day": "13"}], "Language": ["eng"], "ELocationID": ["1356893", "10.1155/2020/1356893"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2020", "PubDate": {"Year": "2020"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Antioxidant Effects and Mechanisms of Medicinal Plants and Their Bioactive Compounds for the Prevention and Treatment of Type 2 Diabetes: An Updated Review.", "Pagination": {"StartPage": "1356893", "MedlinePgn": "1356893"}, "Abstract": {"AbstractText": ["Diabetes mellitus is a metabolic disorder that majorly affects the endocrine gland, and it is symbolized by hyperglycemia and glucose intolerance owing to deficient insulin secretory responses and beta cell dysfunction. This ailment affects as many as 451 million people worldwide, and it is also one of the leading causes of death. In spite of the immense advances made in the development of orthodox antidiabetic drugs, these drugs are often considered not successful for the management and treatment of T2DM due to the myriad side effects associated with them. Thus, the exploration of medicinal herbs and natural products as therapeutic sources for the treatment of T2DM is promoted because they have little or no side effects. Bioactive molecules isolated from natural sources have been proven to lower blood glucose levels <i>via</i> regulating one or more of the following mechanisms: improvement of beta cell function, insulin resistance, glucose (re)absorption, and glucagon-like peptide-1 homeostasis. In recent times, the mechanisms of action of different bioactive molecules with antidiabetic properties and phytochemistry are gaining a lot of attention in the area of drug discovery. This review article presents an update of the findings from clinical research into medicinal plant therapy for T2DM."], "CopyrightInformation": "Copyright \u00a9 2020 Jeremiah Oshiomame Unuofin and Sogolo Lucky Lebelo."}, "AuthorList": [{"Identifier": ["0000-0002-7460-9594"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life and Consumer Sciences, University of South Africa, Cnr. Christiaan de Wet and Pioneer Ave., Private Bag X6, Florida 1710, South Africa."}], "LastName": "Unuofin", "ForeName": "Jeremiah Oshiomame", "Initials": "JO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life and Consumer Sciences, University of South Africa, Cnr. Christiaan de Wet and Pioneer Ave., Private Bag X6, Florida 1710, South Africa."}], "LastName": "Lebelo", "ForeName": "Sogolo Lucky", "Initials": "SL"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "International Diabetes Federation. IDF Diabetes Atlas 2017. Eighth 2017.", "ArticleIdList": ["35914061"]}, {"Citation": "Cho N. H., Shaw J. E., Karuranga S., et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice. 2018;138:271\u2013281. doi: 10.1016/j.diabres.2018.02.023.", "ArticleIdList": ["10.1016/j.diabres.2018.02.023", "29496507"]}, {"Citation": "Ogurtsova K., da Rocha Fernandes J. D., Huang Y., et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical Practice. 2017;128:40\u201350. doi: 10.1016/j.diabres.2017.03.024.", "ArticleIdList": ["10.1016/j.diabres.2017.03.024", "28437734"]}, {"Citation": "International Diabetes Federation (IDF) IDF Diabetes Altas 2017. 8th 2017.", "ArticleIdList": ["35914061"]}, {"Citation": "Du Toit L., Biesman-Simons T., Levy N., Dave J. A. A practical approach to managing diabetes in the perioperative period. South African Medical Journal. 2018;108(5):p. 369. doi: 10.7196/samj.2018.v108i5.13311.", "ArticleIdList": ["10.7196/samj.2018.v108i5.13311"]}, {"Citation": "IDF, International Diabetes Federation. IDF Diabetes Atlas. 7th. Brussels, Belgium: International Diabetes Federation; 2015.   https://www.diabetesatlas.org.", "ArticleIdList": ["35914061"]}, {"Citation": "World Bank. World Health Organization Global Health Expenditure Database, World Bank Group - Open Knowledge Repository; 2016."}, {"Citation": "Zimmet P. Z., Magliano D. J., Herman W. H., Shaw J. E. Diabetes: a 21st century challenge. The Lancet Diabetes and Endocrinology. 2014;2(1):56\u201364. doi: 10.1016/S2213-8587(13)70112-8.", "ArticleIdList": ["10.1016/S2213-8587(13)70112-8", "24622669"]}, {"Citation": "Tuomi T., Santoro N., Caprio S., Cai M., Weng J., Groop L. The many faces of diabetes: a disease with increasing heterogeneity. The Lancet. 2014;383(9922):1084\u20131094. doi: 10.1016/S0140-6736(13)62219-9.", "ArticleIdList": ["10.1016/S0140-6736(13)62219-9", "24315621"]}, {"Citation": "Kahn S. E., Cooper M. E., Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. The Lancet. 2014;383(9922):1068\u20131083. doi: 10.1016/S0140-6736(13)62154-6.", "ArticleIdList": ["10.1016/S0140-6736(13)62154-6", "PMC4226760", "24315620"]}, {"Citation": "Brahmachari G. Bio-flavonoids with promising anti-diabetic potentials: a critical survey. Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry. 2011. pp. 187\u2013212."}, {"Citation": "Johansen J., Harris A. K., Rychly D. J., Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical pratice. Cardiovascular Diabetology. 2005;4(1):p. 5. doi: 10.1186/1475-2840-4-5.", "ArticleIdList": ["10.1186/1475-2840-4-5", "PMC1131912", "15862133"]}, {"Citation": "Forcados G. E., James D. B., Sallau A. B., Muhammad A., Mabeta P. Oxidative stress and carcinogenesis: potential of phytochemicals in breast cancer therapy. Nutrition and Cancer. 2017;69(3):365\u2013374. doi: 10.1080/01635581.2017.1267777.", "ArticleIdList": ["10.1080/01635581.2017.1267777", "28103111"]}, {"Citation": "Pisoschi A. M., Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. European Journal of Medicinal Chemistry. 2015;97:55\u201374. doi: 10.1016/j.ejmech.2015.04.040.", "ArticleIdList": ["10.1016/j.ejmech.2015.04.040", "25942353"]}, {"Citation": "Drummond G. R., Selemidis S., Griendling K. K., Sobey C. G. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nature Reviews Drug Discovery. 2011;10(6):453\u2013471. doi: 10.1038/nrd3403.", "ArticleIdList": ["10.1038/nrd3403", "PMC3361719", "21629295"]}, {"Citation": "Pacher P., Beckman J. S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiological Reviews. 2007;87(1):315\u2013424. doi: 10.1152/physrev.00029.2006.", "ArticleIdList": ["10.1152/physrev.00029.2006", "PMC2248324", "17237348"]}, {"Citation": "Zhang D. X., Gutterman D. D. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology. 2007;292(5):H2023\u2013H2031. doi: 10.1152/ajpheart.01283.2006.", "ArticleIdList": ["10.1152/ajpheart.01283.2006", "17237240"]}, {"Citation": "Pitocco D., Tesauro M., Alessandro R., Ghirlanda G., Cardillo C. Oxidative stress in diabetes: implications for vascular and other complications. International Journal of Molecular Sciences. 2013;14(11):21525\u201321550. doi: 10.3390/ijms141121525.", "ArticleIdList": ["10.3390/ijms141121525", "PMC3856020", "24177571"]}, {"Citation": "Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology. 2007;39(1):44\u201384. doi: 10.1016/j.biocel.2006.07.001.", "ArticleIdList": ["10.1016/j.biocel.2006.07.001", "16978905"]}, {"Citation": "Lazo-de-la-Vega-Monroy M.-L., Fernndez-Mej C. Oxidative Stress and Chronic Degenerative Diseases - a Role for Antioxidants. IntechOpen; 2013. Oxidative stress in diabetes mellitus and the role of vitamins with antioxidant actions.", "ArticleIdList": ["10.5772/51788"]}, {"Citation": "H\u00f6hn A., Jung T., Grune T. Pathophysiological importance of aggregated damaged proteins. Free Radical Biology and Medicine. 2014;71:70\u201389. doi: 10.1016/j.freeradbiomed.2014.02.028.", "ArticleIdList": ["10.1016/j.freeradbiomed.2014.02.028", "24632383"]}, {"Citation": "Weber D., Davies M. J., Grune T. Determination of protein carbonyls in plasma, cell extracts, tissue homogenates, isolated proteins: focus on sample preparation and derivatization conditions. Redox Biology. 2015;5:367\u2013380. doi: 10.1016/j.redox.2015.06.005.", "ArticleIdList": ["10.1016/j.redox.2015.06.005", "PMC4506980", "26141921"]}, {"Citation": "Liou G. Y., Storz P. Reactive oxygen species in cancer. Free Radical Research. 2010;44(5):479\u2013496. doi: 10.3109/10715761003667554.", "ArticleIdList": ["10.3109/10715761003667554", "PMC3880197", "20370557"]}, {"Citation": "Tsai E. C., Hirsch I. B., Brunzell J. D., Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes. 1994;43(8):1010\u20131014. doi: 10.2337/diabetes.43.8.1010.", "ArticleIdList": ["10.2337/diabetes.43.8.1010", "8039594"]}, {"Citation": "Kawamura M., Heinecke J. W., Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. Journal of Clinical Investigation. 1994;94(2):771\u2013778. doi: 10.1172/JCI117396.", "ArticleIdList": ["10.1172/JCI117396", "PMC296157", "8040332"]}, {"Citation": "Fisher A. B., Zhang Q. Encyclopedia of Respiratory Medicine. Academic Press; 2006. NADPH and NADPH oxidase; pp. 77\u201384.", "ArticleIdList": ["10.1016/b0-12-370879-6/00252-0"]}, {"Citation": "Yadav N., Kumar S., Marlowe T., et al. Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents. Cell Death & Disease. 2015;6(11):e1969\u2013e1969. doi: 10.1038/cddis.2015.305.", "ArticleIdList": ["10.1038/cddis.2015.305", "PMC4670921", "26539916"]}, {"Citation": "Hill M. M., Adrain C., Duriez P. J., Creagh E. M., Martin S. J. Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. The EMBO Journal. 2004;23(10):2134\u20132145. doi: 10.1038/sj.emboj.7600210.", "ArticleIdList": ["10.1038/sj.emboj.7600210", "PMC424369", "15103327"]}, {"Citation": "Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews. 2002;23(5):599\u2013622. doi: 10.1210/er.2001-0039.", "ArticleIdList": ["10.1210/er.2001-0039", "12372842"]}, {"Citation": "Bhattacharya S., Sil P. Role of plant-derived polyphenols in reducing oxidative stress-mediated diabetic complications. Reactive Oxygen Species. 2018;5 doi: 10.20455/ros.2018.811.", "ArticleIdList": ["10.20455/ros.2018.811"]}, {"Citation": "Mart\u00edn-Gall\u00e1n P., Carrascosa A., Gussiny\u00e9 M., Dom\u00ednguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radical Biology and Medicine. 2003;34(12):1563\u20131574. doi: 10.1016/S0891-5849(03)00185-0.", "ArticleIdList": ["10.1016/S0891-5849(03)00185-0", "12788476"]}, {"Citation": "Rains J. L., Jain S. K. Oxidative stress, insulin signaling, and diabetes. Free Radical Biology and Medicine. 2011;50(5):567\u2013575. doi: 10.1016/j.freeradbiomed.2010.12.006.", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.12.006", "PMC3557825", "21163346"]}, {"Citation": "Grimsrud P. A., Xie H., Griffin T. J., Bernlohr D. A. Oxidative stress and covalent modification of protein with bioactive aldehydes. Journal of Biological Chemistry. 2008;283(32):21837\u201321841. doi: 10.1074/jbc.R700019200.", "ArticleIdList": ["10.1074/jbc.R700019200", "PMC2494933", "18445586"]}, {"Citation": "Muellenbach E. A., Diehl C. J., Teachey M. K., et al. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant \u03b1-lipoic acid on insulin resistance in the obese Zucker rat. Metabolism. 2008;57(10):1465\u20131472. doi: 10.1016/j.metabol.2008.05.018.", "ArticleIdList": ["10.1016/j.metabol.2008.05.018", "PMC2610286", "18803954"]}, {"Citation": "Pierce A., Mirzaei H., Muller F., et al. GAPDH is conformationally and functionally altered in association with oxidative stress in mouse models of amyotrophic lateral sclerosis. Journal of Molecular Biology. 2008;382(5):1195\u20131210. doi: 10.1016/j.jmb.2008.07.088.", "ArticleIdList": ["10.1016/j.jmb.2008.07.088", "PMC6348903", "18706911"]}, {"Citation": "P\u00e9rez-Matute P., Zulet M. A., Mart\u00ednez J. A. Reactive species and diabetes: counteracting oxidative stress to improve health. Current Opinion in Pharmacology. 2009;9(6):771\u2013779. doi: 10.1016/j.coph.2009.08.005.", "ArticleIdList": ["10.1016/j.coph.2009.08.005", "19766058"]}, {"Citation": "Tangvarasittichai S., Poonsub P., Tangvarasittichai O., Sirigulsatien V. Serum levels of malondialdehyde in type 2 diabetes mellitus Thai subjects. Siriraj Medical Journal. 2009;61(1):p. 26."}, {"Citation": "Moreira P. I., Sayre L. M., Zhu X., Nunomura A., Smith M. A., Perry G. Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease. Methods in Molecular Biology. 2010;610:419\u2013434. doi: 10.1007/978-1-60327-029-8_25.", "ArticleIdList": ["10.1007/978-1-60327-029-8_25", "PMC5914163", "20013193"]}, {"Citation": "Rahmanto A. S., Morgan P. E., Hawkins C. L., Davies M. J. Cellular effects of peptide and protein hydroperoxides. Free Radical Biology and Medicine. 2010;48(8):1071\u20131078. doi: 10.1016/j.freeradbiomed.2010.01.025.", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.01.025", "20109544"]}, {"Citation": "Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54 doi: 10.2337/diabetes.54.6.1615.", "ArticleIdList": ["10.2337/diabetes.54.6.1615", "15919781"]}, {"Citation": "Yan L. J. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. Journal of Diabetes Research. 2014;2014:11. doi: 10.1155/2014/137919.137919", "ArticleIdList": ["10.1155/2014/137919", "PMC4082845", "25019091"]}, {"Citation": "Steinberg H., Baron A. Vascular function, insulin resistance and fatty acids. Diabetologia. 2002;45(5, article 800):623\u2013634. doi: 10.1007/s00125-002-0800-2.", "ArticleIdList": ["10.1007/s00125-002-0800-2", "12107742"]}, {"Citation": "Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813\u2013820. doi: 10.1038/414813a.", "ArticleIdList": ["10.1038/414813a", "11742414"]}, {"Citation": "Aiello L. P., Cahill M. T., Cavallerano J. D. Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy. Eye. 2004;18(2):117\u2013125. doi: 10.1038/sj.eye.6700585.", "ArticleIdList": ["10.1038/sj.eye.6700585", "14762400"]}, {"Citation": "Geraldes P., King G. L. Activation of protein kinase C isoforms and its impact on diabetic complications. Circulation Research. 2010;106(8):1319\u20131331. doi: 10.1161/CIRCRESAHA.110.217117.", "ArticleIdList": ["10.1161/CIRCRESAHA.110.217117", "PMC2877591", "20431074"]}, {"Citation": "Bennett S. P., Griffiths G. D., Schor A. M., Leese G. P., Schor S. L. Growth factors in the treatment of diabetic foot ulcers. British Journal of Surgery. 2003;90(2):133\u2013146. doi: 10.1002/bjs.4019.", "ArticleIdList": ["10.1002/bjs.4019", "12555288"]}, {"Citation": "Pathak D., Gupta A., Kamble B., Kuppusamy G., Suresh B. Oral targeting of protein kinase C receptor: promising route for diabetic retinopathy? Current Drug Delivery. 2012;9(4):405\u2013413. doi: 10.2174/156720112801323080.", "ArticleIdList": ["10.2174/156720112801323080", "22520069"]}, {"Citation": "Shi G.-J., Shi G.-R., Zhou J.-y., et al. Involvement of growth factors in diabetes mellitus and its complications: a general review. Biomedicine and Pharmacotherapy. 2018;101:510\u2013527. doi: 10.1016/j.biopha.2018.02.105.", "ArticleIdList": ["10.1016/j.biopha.2018.02.105", "29505922"]}, {"Citation": "Naidu P. B., Uddandrao V. V. S., Naik R. R., et al. Effects of S-allylcysteine on biomarkers of the polyol pathway in rats with type 2 diabetes. Canadian Journal of Diabetes. 2016;40(5):442\u2013448. doi: 10.1016/j.jcjd.2016.03.006.", "ArticleIdList": ["10.1016/j.jcjd.2016.03.006", "27373435"]}, {"Citation": "Sharavana G., Joseph G. S., Baskaran V. Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model. European Journal of Nutrition. 2017;56(8):2475\u20132485. doi: 10.1007/s00394-016-1283-0.", "ArticleIdList": ["10.1007/s00394-016-1283-0", "27488609"]}, {"Citation": "Koya D., Jirousek M. R., Lin Y. W., Ishii H., Kuboki K., King G. L. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. Journal of Clinical Investigation. 1997;100(1):115\u2013126. doi: 10.1172/jci119503.", "ArticleIdList": ["10.1172/jci119503", "PMC508171", "9202063"]}, {"Citation": "Huang P., Zhang Y. J., Huang Y., Zhao J. J., Jiang T., Zhang N. Effect of PKC signalling pathway and aldose reductase on expression of fibronectin induced by transforming growth factor-\u03b21 in human mesangial cells. Chinese Journal of Pathology. 2010;39(6):405\u2013409.", "ArticleIdList": ["21055159"]}, {"Citation": "Degenhardt T. P., Thorpe S. R., Baynes J. W. Chemical modification of proteins by methylglyoxal. Cellular and Molecular Biology (Noisy-le-Grand, France) 1998;44(7):1139\u20131145.", "ArticleIdList": ["9846896"]}, {"Citation": "Sun K., Wang W., Wang C., et al. AGEs trigger autophagy in diabetic skin tissues and fibroblasts. Biochemical and Biophysical Research Communications. 2016;471(3):355\u2013360. doi: 10.1016/j.bbrc.2016.02.020.", "ArticleIdList": ["10.1016/j.bbrc.2016.02.020", "26872427"]}, {"Citation": "Bhat S., Mary S., Giri A. P., Kulkarni M. J. Mechanisms of Vascular Defects in Diabetes Mellitus. Springer; 2017. Advanced Glycation End Products (AGEs) in diabetic complications; pp. 423\u2013449.", "ArticleIdList": ["10.1007/978-3-319-60324-7_19"]}, {"Citation": "Piperi C., Adamopoulos C., Dalagiorgou G., Diamanti-Kandarakis E., Papavassiliou A. G. Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. Journal of Clinical Endocrinology and Metabolism. 2012;97(7):2231\u20132242. doi: 10.1210/jc.2011-3408.", "ArticleIdList": ["10.1210/jc.2011-3408", "22508704"]}, {"Citation": "Thomson M., al-Qattan K. K., JS D., Ali M. Anti-diabetic and anti-oxidant potential of aged garlic extract (AGE) in streptozotocin-induced diabetic rats. BMC Complementary and Alternative Medicine. 2015;16(1, article 992) doi: 10.1186/s12906-016-0992-5.", "ArticleIdList": ["10.1186/s12906-016-0992-5", "PMC4719681", "26786785"]}, {"Citation": "Yiu W. H., Wong D. W. L., Wu H. J., et al. Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress. Kidney International. 2016;89(2):386\u2013398. doi: 10.1038/ki.2015.331.", "ArticleIdList": ["10.1038/ki.2015.331", "26536000"]}, {"Citation": "Kay A. M., Simpson C. L., Stewart J. A. The role of AGE/RAGE signaling in diabetes-mediated vascular calcification. Journal of Diabetes Research. 2016;2016:8. doi: 10.1155/2016/6809703.6809703", "ArticleIdList": ["10.1155/2016/6809703", "PMC4980539", "27547766"]}, {"Citation": "Suchal K., Malik S., Khan S. I., et al. Protective effect of mangiferin on myocardial ischemia-reperfusion injury in streptozotocin-induced diabetic rats: role of AGE-RAGE/MAPK pathways. Scientific Reports. 2017;7(1) doi: 10.1038/srep42027.", "ArticleIdList": ["10.1038/srep42027", "PMC5299420", "28181586"]}, {"Citation": "Qiu Y. Y., Tang L. Q., Wei W. Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy. Molecular and Cellular Endocrinology. 2017;443:89\u2013105. doi: 10.1016/j.mce.2017.01.009.", "ArticleIdList": ["10.1016/j.mce.2017.01.009", "28087385"]}, {"Citation": "Ram M., Singh V., Kumawat S., Kant V., Tandan S. K., Kumar D. Bilirubin modulated cytokines, growth factors and angiogenesis to improve cutaneous wound healing process in diabetic rats. International Immunopharmacology. 2016;30:137\u2013149. doi: 10.1016/j.intimp.2015.11.037.", "ArticleIdList": ["10.1016/j.intimp.2015.11.037", "26679676"]}, {"Citation": "Goldfarb S., Ziyadeh F. N., Kern E. F. O., Simmons D. A. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats. Diabetes. 1991;40(4):465\u2013471. doi: 10.2337/diab.40.4.465.", "ArticleIdList": ["10.2337/diab.40.4.465", "2010046"]}, {"Citation": "Wilson D., Bohren K., Gabbay K., Quiocho F. An unlikely sugar substrate site in the 1.65\u2009A structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science. 1992;257(5066):81\u201384. doi: 10.1126/science.1621098.", "ArticleIdList": ["10.1126/science.1621098", "1621098"]}, {"Citation": "Shaw S., Wang X., Redd H., Alexander G. D., Isales C. M., Marrero M. B. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. Journal of Biological Chemistry. 2003;278(33):30634\u201330641. doi: 10.1074/jbc.m305008200.", "ArticleIdList": ["10.1074/jbc.m305008200", "12777386"]}, {"Citation": "Khanra R., Bhattacharjee N., Dua T. K., et al. Taraxerol, a pentacyclic triterpenoid, from Abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats. Biomedicine & Pharmacotherapy. 2017;94:726\u2013741. doi: 10.1016/j.biopha.2017.07.112.", "ArticleIdList": ["10.1016/j.biopha.2017.07.112", "28802226"]}, {"Citation": "Engerman R. L., Kern T. S., Larson M. E. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs. Diabetologia. 1994;37(2):141\u2013144. doi: 10.1007/s001250050084.", "ArticleIdList": ["10.1007/s001250050084", "8163047"]}, {"Citation": "Garcia Soriano F., Vir\u00e1g L., Jagtap P., et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nature Medicine. 2001;7(1):108\u2013113. doi: 10.1038/83241.", "ArticleIdList": ["10.1038/83241", "11135624"]}, {"Citation": "Soltesova Prnova M., Ballekova J., Gajdosikova A., Gajdosik A., Stefek M. A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocin-induced diabetic rats. Physiological Research. 2015;64(4):587\u2013591.", "ArticleIdList": ["26291727"]}, {"Citation": "Boesten D. M. P. H. J., Von Ungern-Sternberg S. N. I., Den Hartog G. J. M., Bast A. Protective pleiotropic effect of flavonoids on NAD+ levels in endothelial cells exposed to high glucose. Oxidative Medicine and Cellular Longevity. 2015;2015:7. doi: 10.1155/2015/894597.894597", "ArticleIdList": ["10.1155/2015/894597", "PMC4477254", "26180598"]}, {"Citation": "van Dam P. S., Gispen W.-H., Bravenboer B., van Asbeck B. S., Erkelens D. W., Marx J. J. M. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes/Metabolism Reviews. 1995;11(3):181\u2013192. doi: 10.1002/dmr.5610110303.", "ArticleIdList": ["10.1002/dmr.5610110303", "8536540"]}, {"Citation": "Shakeel M. Recent advances in understanding the role of oxidative stress in diabetic neuropathy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2015;9(4):373\u2013378. doi: 10.1016/j.dsx.2014.04.029.", "ArticleIdList": ["10.1016/j.dsx.2014.04.029", "25470637"]}, {"Citation": "Li F., Zhao Y. B., Wang D. K., Zou X., Fang K., Wang K. F. Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells. Journal of Huazhong University of Science and Technology [Medical Sciences] 2016;36(1, article 1543):64\u201369. doi: 10.1007/s11596-016-1543-5.", "ArticleIdList": ["10.1007/s11596-016-1543-5", "26838742"]}, {"Citation": "Jagdale A. D., Bavkar L. N., More T. A., Joglekar M. M., Arvindekar A. U. Strong inhibition of the polyol pathway diverts glucose flux to protein glycation leading to rapid establishment of secondary complications in diabetes mellitus. Journal of Diabetes and its Complications. 2016;30(3):398\u2013405. doi: 10.1016/j.jdiacomp.2016.01.001.", "ArticleIdList": ["10.1016/j.jdiacomp.2016.01.001", "26896333"]}, {"Citation": "Sheela D. L., Nazeem P. A., Narayanankutty A., et al. Coconut phytocompounds inhibits polyol pathway enzymes: implication in prevention of microvascular diabetic complications. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2017;127:20\u201324. doi: 10.1016/j.plefa.2017.10.004.", "ArticleIdList": ["10.1016/j.plefa.2017.10.004", "29156154"]}, {"Citation": "Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circulation Research. 2010;107(9):1058\u20131070. doi: 10.1161/CIRCRESAHA.110.223545.", "ArticleIdList": ["10.1161/CIRCRESAHA.110.223545", "PMC2996922", "21030723"]}, {"Citation": "Beriault D., Shi Y., Werstuck G. Investigating the role of the hexosamine biosynthesis pathway in diabetic atherosclerosis. Canadian Journal of Cardiology. 2013;29(10, article S254) doi: 10.1016/j.cjca.2013.07.417.", "ArticleIdList": ["10.1016/j.cjca.2013.07.417"]}, {"Citation": "Marsh S. A., Dell\u2019Italia L. J., Chatham J. C. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice. Amino Acids. 2011;40(3):819\u2013828. doi: 10.1007/s00726-010-0699-8.", "ArticleIdList": ["10.1007/s00726-010-0699-8", "PMC3025273", "20676904"]}, {"Citation": "Taparra K., Tran P. T., Zachara N. E. Hijacking the hexosamine biosynthetic pathway to promote EMT-mediated neoplastic phenotypes. Frontiers in Oncology. 2016;6 doi: 10.3389/fonc.2016.00085.", "ArticleIdList": ["10.3389/fonc.2016.00085", "PMC4834358", "27148477"]}, {"Citation": "Chiaradonna F., Ricciardiello F., Palorini R. The nutrient-sensing hexosamine biosynthetic pathway as the hub of cancer metabolic rewiring. Cells. 2018;7(6):p. 53. doi: 10.3390/cells7060053.", "ArticleIdList": ["10.3390/cells7060053", "PMC6025041", "29865240"]}, {"Citation": "Qin C. X., Sleaby R., Davidoff A. J., et al. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications. Pharmacological Research. 2017;116:45\u201356. doi: 10.1016/j.phrs.2016.12.016.", "ArticleIdList": ["10.1016/j.phrs.2016.12.016", "27988387"]}, {"Citation": "Virkam\u00e4ki A., Daniels M. C., H\u00e4m\u00e4l\u00e4inen S., Utriainen T., Mcclain D., Yki-J\u00e4rvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology. 1997;138(6):2501\u20132507. doi: 10.1210/endo.138.6.5172.", "ArticleIdList": ["10.1210/endo.138.6.5172", "9165041"]}, {"Citation": "Schleicher E. D., Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney International. 2000;58:S13\u2013S18. doi: 10.1046/j.1523-1755.2000.07703.x.", "ArticleIdList": ["10.1046/j.1523-1755.2000.07703.x", "10997685"]}, {"Citation": "Sayeski P. P., Kudlow J. E. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-\u03b1 gene transcription. Journal of Biological Chemistry. 1996;271(25):15237\u201315243. doi: 10.1074/jbc.271.25.15237.", "ArticleIdList": ["10.1074/jbc.271.25.15237", "8663078"]}, {"Citation": "Kolm-Litty V., Sauer U., Nerlich A., Lehmann R., Schleicher E. D. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. Journal of Clinical Investigation. 1998;101(1):160\u2013169. doi: 10.1172/jci119875.", "ArticleIdList": ["10.1172/jci119875", "PMC508552", "9421478"]}, {"Citation": "Pang Y., Bounelis P., Chatham J. C., Marchase R. B. Hexosamine pathway is responsible for inhibition by diabetes of phenylephrine-induced inotropy. Diabetes. 2004;53(4):1074\u20131081. doi: 10.2337/diabetes.53.4.1074.", "ArticleIdList": ["10.2337/diabetes.53.4.1074", "15047624"]}, {"Citation": "Yaribeygi H., Atkin S. L., Sahebkar A. A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress. Journal of Cellular Physiology. 2019;234(2):1300\u20131312. doi: 10.1002/jcp.27164.", "ArticleIdList": ["10.1002/jcp.27164", "30146696"]}, {"Citation": "Fakhruddin S., Alanazi W., Jackson K. E. Diabetes-induced reactive oxygen species: mechanism of their generation and role in renal injury. Journal of Diabetes Research. 2017;2017:30. doi: 10.1155/2017/8379327.8379327", "ArticleIdList": ["10.1155/2017/8379327", "PMC5253173", "28164134"]}, {"Citation": "Liu Y., Fiskum G., Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. Journal of Neurochemistry. 2002;80(5):780\u2013787. doi: 10.1046/j.0022-3042.2002.00744.x.", "ArticleIdList": ["10.1046/j.0022-3042.2002.00744.x", "11948241"]}, {"Citation": "Turrens J. F. Mitochondrial formation of reactive oxygen species. The Journal of Physiology. 2003;552(2):335\u2013344. doi: 10.1113/jphysiol.2003.049478.", "ArticleIdList": ["10.1113/jphysiol.2003.049478", "PMC2343396", "14561818"]}, {"Citation": "Venditti P., Di Stefano L., Di Meo S. Mitochondrial metabolism of reactive oxygen species. Mitochondrion. 2013;13(2):71\u201382. doi: 10.1016/j.mito.2013.01.008.", "ArticleIdList": ["10.1016/j.mito.2013.01.008", "23376030"]}, {"Citation": "Lenzen S., Drinkgern J., Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology & Medicine. 1996;20(3):463\u2013466. doi: 10.1016/0891-5849(96)02051-5.", "ArticleIdList": ["10.1016/0891-5849(96)02051-5", "8720919"]}, {"Citation": "Raza H., Prabu S. K., John A., Avadhani N. G. Impaired mitochondrial respiratory functions and oxidative stress in streptozotocin-induced diabetic rats. International Journal of Molecular Sciences. 2011;12(5):3133\u20133147. doi: 10.3390/ijms12053133.", "ArticleIdList": ["10.3390/ijms12053133", "PMC3116180", "21686174"]}, {"Citation": "Kakkar R., Kalra J., Mantha S. V., Prasad K. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Molecular and Cellular Biochemistry. 1995;151(2):113\u2013119. doi: 10.1007/bf01322333.", "ArticleIdList": ["10.1007/bf01322333", "8569756"]}, {"Citation": "Chatuphonprasert W., Lao-Ong T., Jarukamjorn K. Improvement of superoxide dismutase and catalase in streptozotocin-nicotinamide-induced type 2-diabetes in mice by berberine and glibenclamide. Pharmaceutical Biology. 2014;52(4):419\u2013427. doi: 10.3109/13880209.2013.839714.", "ArticleIdList": ["10.3109/13880209.2013.839714", "24188560"]}, {"Citation": "Hagglof B., Marklund S. L., Holmgren G. CuZn superoxide dismutase, Mn superoxide dismutase, catalase and glutathione peroxidase in lymphocytes and erythrocytes in insulin-dependent diabetic children. Acta Endocrinologica. 1983;102(2):235\u2013239. doi: 10.1530/acta.0.1020235.", "ArticleIdList": ["10.1530/acta.0.1020235", "6338671"]}, {"Citation": "Sindhu R. K., Koo J. R., Roberts C. K., Vaziri N. D. Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies. Clinical and Experimental Hypertension. 2004;26(1):43\u201353. doi: 10.1081/ceh-120027330.", "ArticleIdList": ["10.1081/ceh-120027330", "15000296"]}, {"Citation": "Turkseven S., Kruger A., Mingone C. J., et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. American Journal of Physiology-Heart and Circulatory Physiology. 2005;289(2):H701\u2013H707. doi: 10.1152/ajpheart.00024.2005.", "ArticleIdList": ["10.1152/ajpheart.00024.2005", "15821039"]}, {"Citation": "Shailey S., Basir S. F. Protective role of Azadirachta indica against oxidative damage in skeletal and cardiac muscle of alloxan diabetic rats. International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4"}, {"Citation": "Kakkar R., Mantha S. V., Radhi J., Prasad K., Kalra J. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clinical Science. 1998;94(6):623\u2013632. doi: 10.1042/cs0940623.", "ArticleIdList": ["10.1042/cs0940623", "9854460"]}, {"Citation": "Simonyan M. A., Gevorkyan D. M., Mkhitaryan V. G. Quantitative changes in Cu, Zn-activated superoxide dismutase and catalase in the liver of rats with alloxan diabetes. Bulletin of Experimental Biology and Medicine. 1987;103(3):339\u2013341. doi: 10.1007/bf00840555.", "ArticleIdList": ["10.1007/bf00840555"]}, {"Citation": "Wolff S. P., Dean R. T. Glucose autoxidation and protein modification. The potential role of \u201cautoxidative glycosylation\u201d in diabetes. Biochemical Journal. 1987;245(1):243\u2013250. doi: 10.1042/bj2450243.", "ArticleIdList": ["10.1042/bj2450243", "PMC1148106", "3117042"]}, {"Citation": "Hunt J. V., Dean R. T., Wolff S. P. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing, Biochemical Journal. 1988;256(1):205\u2013212. doi: 10.1042/bj2560205.", "ArticleIdList": ["10.1042/bj2560205", "PMC1135388", "2851978"]}, {"Citation": "Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation. 2004;114(12):1752\u20131761. doi: 10.1172/JCI21625.", "ArticleIdList": ["10.1172/JCI21625", "PMC535065", "15599400"]}, {"Citation": "Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biology. 2015;4:180\u2013183. doi: 10.1016/j.redox.2015.01.002.", "ArticleIdList": ["10.1016/j.redox.2015.01.002", "PMC4309861", "25588755"]}, {"Citation": "Sj\u00f6holm \u00c5., Nystr\u00f6m T. Inflammation and the etiology of type 2 diabetes. Diabetes/Metabolism Research and Reviews. 2006;22(1):4\u201310. doi: 10.1002/dmrr.568.", "ArticleIdList": ["10.1002/dmrr.568", "15991254"]}, {"Citation": "Donath M. Y., B\u00f6ni-Schnetzler M., Ellingsgaard H., Ehses J. A. Islet inflammation impairs the pancreatic \u03b2-cell in type 2 diabetes. Physiology. 2009;24(6):325\u2013331. doi: 10.1152/physiol.00032.2009.", "ArticleIdList": ["10.1152/physiol.00032.2009", "19996363"]}, {"Citation": "Sandberg M., Jansson L. Effects of cyclooxygenase inhibition on insulin release and pancreatic islet blood flow in rats. Upsala Journal of Medical Sciences. 2014;119(4):316\u2013323. doi: 10.3109/03009734.2014.964381.", "ArticleIdList": ["10.3109/03009734.2014.964381", "PMC4248071", "25291145"]}, {"Citation": "Fu J. Y., Masferrer J. L., Seibert K., Raz A., Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. Journal of Biological Chemistry. 1990;265(28):16737\u201316740.", "ArticleIdList": ["2120205"]}, {"Citation": "Crofford L. J. COX-1 and COX-2 tissue expression: implications and predictions. The Journal of Rheumatology. 1997;49:15\u201319.", "ArticleIdList": ["9249646"]}, {"Citation": "Vane J. R., Bakhle Y. S., Botting R. M. Cyclooxygenases 1 and 2. Annual Review of Pharmacology and Toxicology. 1998;38(1):97\u2013120. doi: 10.1146/annurev.pharmtox.38.1.97.", "ArticleIdList": ["10.1146/annurev.pharmtox.38.1.97", "9597150"]}, {"Citation": "Chandrasekharan N. V., Dai H., Roos K. L. T., et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(21):13926\u201313931. doi: 10.1073/pnas.162468699.", "ArticleIdList": ["10.1073/pnas.162468699", "PMC129799", "12242329"]}, {"Citation": "Warner T. D., Mitchell J. A. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proceedings of the National Academy of Sciences. 2002;99(21):13371\u201313373. doi: 10.1073/pnas.222543099.", "ArticleIdList": ["10.1073/pnas.222543099", "PMC129677", "12374850"]}, {"Citation": "Shehata H. Drugs and Drug Therapy. 4th. Elsevier Ltd; 2010."}, {"Citation": "Zurier R. B. Kelley\u2019s Textbook of Rheumatology. Elsevier; 2013. Prostaglandins, leukotrienes, and related compounds; pp. 340\u2013357.", "ArticleIdList": ["10.1016/b978-1-4377-1738-9.00024-4"]}, {"Citation": "Pop-Busui R., Kellogg A., Cheng H. Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy. Current Drug Targets. 2008;9(1):68\u201376. doi: 10.2174/138945008783431691.", "ArticleIdList": ["10.2174/138945008783431691", "18220714"]}, {"Citation": "Kirkby N. S., Zaiss A. K., Wright W. R., et al. Differential COX-2 induction by viral and bacterial PAMPs: consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies. Biochemical and Biophysical Research Communications. 2013;438:249\u2013256. doi: 10.1016/j.bbrc.2013.07.006.", "ArticleIdList": ["10.1016/j.bbrc.2013.07.006", "PMC3759847", "23850620"]}, {"Citation": "Font-Nieves M., Sans-Fons M. G., Gorina R., et al. Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E 2 production in astrocytes. Journal of Biological Chemistry. 2012;287(9):6454\u20136468. doi: 10.1074/jbc.m111.327874.", "ArticleIdList": ["10.1074/jbc.m111.327874", "PMC3307308", "22219191"]}, {"Citation": "Song H., Park J., Bui P. T. C., et al. Bisphenol A induces COX-2 through the mitogen-activated protein kinase pathway and is associated with levels of inflammation-related markers in elderly populations. Environmental Research. 2017;158:490\u2013498. doi: 10.1016/j.envres.2017.07.005.", "ArticleIdList": ["10.1016/j.envres.2017.07.005", "28709031"]}, {"Citation": "Verma S., Chandra H., Banerjee M. Cyclooxygenase 1 (COX1) expression in type 2 diabetes mellitus: a preliminary study from North India. Egyptian Journal of Medical Human Genetics. 2016;17(1):41\u201345. doi: 10.1016/j.ejmhg.2015.07.003.", "ArticleIdList": ["10.1016/j.ejmhg.2015.07.003"]}, {"Citation": "Guo Z., Su W., Allen S., et al. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic / mice. Cardiovascular Research. 2005;67(4):723\u2013735. doi: 10.1016/j.cardiores.2005.04.008.", "ArticleIdList": ["10.1016/j.cardiores.2005.04.008", "15885672"]}, {"Citation": "Szerafin T., Erdei N., F\u00fcl\u00f6p T., et al. Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Circulation Research. 2006;99(5):e12\u2013e17. doi: 10.1161/01.res.0000241051.83067.62.", "ArticleIdList": ["10.1161/01.res.0000241051.83067.62", "16917094"]}, {"Citation": "Redondo S., Ruiz E., Gordillo-Moscoso A., et al. Overproduction of cyclo-oxygenase-2 (COX-2) is involved in the resistance to apoptosis in vascular smooth muscle cells from diabetic patients: a link between inflammation and apoptosis. Diabetologia. 2011;54(1, article 1947):190\u2013199. doi: 10.1007/s00125-010-1947-x.", "ArticleIdList": ["10.1007/s00125-010-1947-x", "20957341"]}, {"Citation": "Cheng H., Fan X., Moeckel G. W., Harris R. C. Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression. Journal of the American Society of Nephrology. 2011;22(7):1240\u20131251. doi: 10.1681/ASN.2010111149.", "ArticleIdList": ["10.1681/ASN.2010111149", "PMC3137572", "21737546"]}, {"Citation": "Cheng H. F., Wang C. J., Moeckel G. W., Zhang M. Z., McKanna J. A., Harris R. C. Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension. Kidney International. 2002;62(3):929\u2013939. doi: 10.1046/j.1523-1755.2002.00520.x.", "ArticleIdList": ["10.1046/j.1523-1755.2002.00520.x", "12164875"]}, {"Citation": "Nasrallah R., Robertson S. J., H\u00e9bert R. L. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2Akita mice. American Journal of Nephrology. 2009;30(4):346\u2013353. doi: 10.1159/000229304.", "ArticleIdList": ["10.1159/000229304", "19609076"]}, {"Citation": "Quilley J., Santos M., Pedraza P. Renal protective effect of chronic inhibition of COX-2 with SC-58236 in streptozotocin-diabetic rats. American Journal of Physiology-Heart and Circulatory Physiology. 2011;300(6):H2316\u2013H2322. doi: 10.1152/ajpheart.01259.2010.", "ArticleIdList": ["10.1152/ajpheart.01259.2010", "PMC3119087", "21441310"]}, {"Citation": "Abdelrahman A. M., Al Suleimani Y. M. Four-week administration of nimesulide, a cyclooxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic rats. Archives of Pharmacal Research. 2008;31(12, article 2155):1584\u20131589. doi: 10.1007/s12272-001-2155-5.", "ArticleIdList": ["10.1007/s12272-001-2155-5", "19099228"]}, {"Citation": "Guengerich F. P. Cytochrome P450: Structure, Mechanism, and Biochemistry. Fourth. Springer; 2015. Human cytochrome P450 enzymes; pp. 473\u2013535.", "ArticleIdList": ["10.1007/978-1-4757-2391-5_14"]}, {"Citation": "Wang Z., Hall S. D., Maya J. F., Li L., Asghar A., Gorski J. C. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. British Journal of Clinical Pharmacology. 2003;55(1):77\u201385. doi: 10.1046/j.1365-2125.2003.01731.x.", "ArticleIdList": ["10.1046/j.1365-2125.2003.01731.x", "PMC1884181", "12534643"]}, {"Citation": "Ortiz de Montellano P. R. Cytochrome P450: Structure, Mechanism, and Biochemistry. Third. Springer; 2005.", "ArticleIdList": ["10.1007/978-1-4757-9939-2"]}, {"Citation": "Bansal S., Liu C. P., Sepuri N. B. V., et al. Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress. Journal of Biological Chemistry. 2010;285(32):24609\u201324619. doi: 10.1074/jbc.M110.121822.", "ArticleIdList": ["10.1074/jbc.M110.121822", "PMC2915697", "20529841"]}, {"Citation": "Shimojo N., Ishizaki T., Imaoka S., Funae Y., Fuji S., Okuda K. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochemical Pharmacology. 1993;46(4):621\u2013627. doi: 10.1016/0006-2952(93)90547-A.", "ArticleIdList": ["10.1016/0006-2952(93)90547-A", "8363636"]}, {"Citation": "Bondoc F. Y., Bao Z., Hu W. Y., et al. Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice. Biochemical Pharmacology. 1999;58(3):461\u2013463. doi: 10.1016/S0006-2952(99)00111-2.", "ArticleIdList": ["10.1016/S0006-2952(99)00111-2", "10424765"]}, {"Citation": "Brash A. R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. Journal of Biological Chemistry. 1999;274(34):23679\u201323682. doi: 10.1074/jbc.274.34.23679.", "ArticleIdList": ["10.1074/jbc.274.34.23679", "10446122"]}, {"Citation": "Niedowicz D. M., Daleke D. L. The role of oxidative stress in diabetic complications. Cell Biochemistry and Biophysics. 2005;43(2):289\u2013330. doi: 10.1385/CBB:43:2:289.", "ArticleIdList": ["10.1385/CBB:43:2:289", "16049352"]}, {"Citation": "Radmark O., Samuelsson B. 5-Lipoxygenase: mechanisms of regulation. Journal of Lipid Research. 2009;50(Supplement):S40\u2013S45. doi: 10.1194/jlr.R800062-JLR200.", "ArticleIdList": ["10.1194/jlr.R800062-JLR200", "PMC2674731", "18987389"]}, {"Citation": "Wen Y., Gu J., Chakrabarti S. K., et al. The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-\u03b1 in macrophages. Endocrinology. 2007;148(3):1313\u20131322. doi: 10.1210/en.2006-0665.", "ArticleIdList": ["10.1210/en.2006-0665", "17170102"]}, {"Citation": "Nagelin M. H., Srinivasan S., Lee J., Nadler J. L., Hedrick C. C. 12/15-Lipoxygenase activity increases the degradation of macrophage ATP-binding cassette transporter G1. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28(10):1811\u20131819. doi: 10.1161/ATVBAHA.108.167908.", "ArticleIdList": ["10.1161/ATVBAHA.108.167908", "PMC2749732", "18635820"]}, {"Citation": "Stavniichuk R., Drel V. R., Shevalye H., et al. Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies. Free Radical Biology and Medicine. 2010;49(6):1036\u20131045. doi: 10.1016/j.freeradbiomed.2010.06.016.", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.06.016", "PMC3056543", "20599608"]}, {"Citation": "Bleich D., Chen S., Zipser B., Sun D., Funk C. D., Nadler J. L. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. Journal of Clinical Investigation. 1999;103(10):1431\u20131436. doi: 10.1172/JCI5241.", "ArticleIdList": ["10.1172/JCI5241", "PMC408453", "10330425"]}, {"Citation": "Furtm\u00fcller P. G., Zederbauer M., Jantschko W., et al. Active site structure and catalytic mechanisms of human peroxidases. Archives of Biochemistry and Biophysics. 2006;445(2):199\u2013213. doi: 10.1016/j.abb.2005.09.017.", "ArticleIdList": ["10.1016/j.abb.2005.09.017", "16288970"]}, {"Citation": "Lazarevic-Pasti T., Leskovac A., Vasic V. Myeloperoxidase inhibitors as potential drugs. Current Drug Metabolism. 2015;16(3):168\u2013190. doi: 10.2174/138920021603150812120640.", "ArticleIdList": ["10.2174/138920021603150812120640", "26279325"]}, {"Citation": "Van Der Veen B. S., De Winther M. P. J., Heeringa P. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxidants and Redox Signaling. 2009;11(11):2899\u20132937. doi: 10.1089/ars.2009.2538.", "ArticleIdList": ["10.1089/ars.2009.2538", "19622015"]}, {"Citation": "Wiersma J. J., Meuwese M. C., van Miert J. N. I., et al. Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Medical Science Monitor. 2008;14(8):CR406\u2013CR410.", "ArticleIdList": ["18667997"]}, {"Citation": "Yaribeygi H., Farrokhi F. R., Rezaee R., Sahebkar A. Oxidative stress induces renal failure: a review of possible molecular pathways. Journal of Cellular Biochemistry. 2018;119(4):2990\u20132998. doi: 10.1002/jcb.26450.", "ArticleIdList": ["10.1002/jcb.26450", "29111576"]}, {"Citation": "Bedard K., Krause K. H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews. 2007;87(1):245\u2013313. doi: 10.1152/physrev.00044.2005.", "ArticleIdList": ["10.1152/physrev.00044.2005", "17237347"]}, {"Citation": "Babior B. M. NADPH oxidase: an update. Blood. 1999;93(5):1464\u20131476. doi: 10.1182/blood.V93.5.1464.", "ArticleIdList": ["10.1182/blood.V93.5.1464", "10029572"]}, {"Citation": "Chen F., Haigh S., Barman S., Fulton D. J. R. From form to function: the role of Nox4 in the cardiovascular system. Frontiers in Physiology. 2012;3 doi: 10.3389/fphys.2012.00412.", "ArticleIdList": ["10.3389/fphys.2012.00412", "PMC3485577", "23125837"]}, {"Citation": "Serrander L., Cartier L., Bedard K., et al. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochemical Journal. 2007;406(1):105\u2013114. doi: 10.1042/BJ20061903.", "ArticleIdList": ["10.1042/BJ20061903", "PMC1948990", "17501721"]}, {"Citation": "Yaribeygi H., Mohammadi M. T., Rezaee R., Sahebkar A. Crocin improves renal function by declining Nox-4, IL-18, and p53 expression levels in an experimental model of diabetic nephropathy. Journal of Cellular Biochemistry. 2018;119(7):6080\u20136093. doi: 10.1002/jcb.26806.", "ArticleIdList": ["10.1002/jcb.26806", "29575259"]}, {"Citation": "Eid A. A., Ford B. M., Block K., et al. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. Journal of Biological Chemistry. 2010;285(48):37503\u201337512. doi: 10.1074/jbc.M110.136796.", "ArticleIdList": ["10.1074/jbc.M110.136796", "PMC2988355", "20861022"]}, {"Citation": "Lee H. J., Lee D. Y., Mariappan M. M., et al. Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells. Journal of Biological Chemistry. 2017;292(14):5665\u20135675. doi: 10.1074/jbc.M116.766758.", "ArticleIdList": ["10.1074/jbc.M116.766758", "PMC5392562", "28188286"]}, {"Citation": "F\u00f6rstermann U., Sessa W. C. Nitric oxide synthases: regulation and function. European Heart Journal. 2012;33(7):829\u2013837. doi: 10.1093/eurheartj/ehr304.", "ArticleIdList": ["10.1093/eurheartj/ehr304", "PMC3345541", "21890489"]}, {"Citation": "Faria A. M., Papadimitriou A., Silva K. C., Lopes De Faria J. M., Lopes De Faria J. B. Uncoupling endothelial nitric oxide synthase is ameliorated by green tea in experimental diabetes by re-establishing tetrahydrobiopterin levels. Diabetes. 2012;61(7):1838\u20131847. doi: 10.2337/db11-1241.", "ArticleIdList": ["10.2337/db11-1241", "PMC3379677", "22586583"]}, {"Citation": "Xia N., F\u00f6rstermann U., Li H. Implication of eNOS uncoupling in cardiovascular disease. Reactive Oxygen Species. 2017;3 doi: 10.20455/ros.2017.807.", "ArticleIdList": ["10.20455/ros.2017.807"]}, {"Citation": "Chen C. A., Wang T. Y., Varadharaj S., et al. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature. 2010;468(7327):1115\u20131118. doi: 10.1038/nature09599.", "ArticleIdList": ["10.1038/nature09599", "PMC3370391", "21179168"]}, {"Citation": "Zweier J. L., Chen C. A., Druhan L. J. S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling. Antioxidants and Redox Signaling. 2011;14(10):1769\u20131775. doi: 10.1089/ars.2011.3904.", "ArticleIdList": ["10.1089/ars.2011.3904", "PMC3078498", "21261471"]}, {"Citation": "Chen C. A., Lin C. H., Druhan L. J., Wang T. Y., Chen Y. R., Zweier J. L. Superoxide induces endothelial nitric-oxide synthase protein thiyl radical formation, a novel mechanism regulating eNOS function and coupling. Journal of Biological Chemistry. 2011;286(33):29098\u201329107. doi: 10.1074/jbc.m111.240127.", "ArticleIdList": ["10.1074/jbc.m111.240127", "PMC3190717", "21666221"]}, {"Citation": "Luo S., Lei H., Qin H., Xia Y. Molecular mechanisms of endothelial NO synthase uncoupling. Current Pharmaceutical Design. 2014;20(22):3548\u20133553. doi: 10.2174/13816128113196660746.", "ArticleIdList": ["10.2174/13816128113196660746", "24180388"]}, {"Citation": "Heitzer T., Krohn K., Albers S., Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia. 2000;43(11):1435\u20131438. doi: 10.1007/s001250051551.", "ArticleIdList": ["10.1007/s001250051551", "11126415"]}, {"Citation": "Satoh M., Fujimoto S., Haruna Y., et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. American Journal of Physiology-Renal Physiology. 2005;288(6):F1144\u2013F1152. doi: 10.1152/ajprenal.00221.2004.", "ArticleIdList": ["10.1152/ajprenal.00221.2004", "15687247"]}, {"Citation": "Parks D. A., Granger D. N. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiologica Scandinavica Supplementum. 1986;548:87\u201399.", "ArticleIdList": ["3529824"]}, {"Citation": "Azenabor A., Erivona R., Adejumo E., Ozuruoke D., Azenabor R. Xanthine oxidase activity in type 2 diabetic Nigerians. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(3):2021\u20132024. doi: 10.1016/j.dsx.2019.04.022.", "ArticleIdList": ["10.1016/j.dsx.2019.04.022", "31235130"]}, {"Citation": "Desco M. C., Asensi M., Marquez R., et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes. 2002;51(4):1118\u20131124. doi: 10.2337/diabetes.51.4.1118.", "ArticleIdList": ["10.2337/diabetes.51.4.1118", "11916934"]}, {"Citation": "Henriksen E. J., Diamond-Stanic M. K., Marchionne E. M. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radical Biology and Medicine. 2011;51(5):993\u2013999. doi: 10.1016/j.freeradbiomed.2010.12.005.", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.12.005", "PMC3071882", "21163347"]}, {"Citation": "Feillet Coudray C. Xanthine oxidase is variably involved in nutritional and physio-pathologic oxidative stress situations. Journal of Physiobiochemical Metabolism. 2013;2(1) doi: 10.4172/2324-8793.1000104.", "ArticleIdList": ["10.4172/2324-8793.1000104"]}, {"Citation": "Domingueti C. P., Sant\u2019Ana Dusse L. M., das Gra\u00e7as Carvalho M., de Sousa L. P., Gomes K. B., Fernandes A. P. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. Journal of Diabetes and its Complications. 2016;30(4):738\u2013745. doi: 10.1016/j.jdiacomp.2015.12.018.", "ArticleIdList": ["10.1016/j.jdiacomp.2015.12.018", "26781070"]}, {"Citation": "Liu J., Wang C., Liu F., Lu Y., Cheng J. Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy. Analytical and Bioanalytical Chemistry. 2015;407(9):2569\u20132579. doi: 10.1007/s00216-015-8481-0.", "ArticleIdList": ["10.1007/s00216-015-8481-0", "25636229"]}, {"Citation": "Tuomilehto J., Lindstr\u00f6m J., Eriksson J. G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine. 2001;344(18):1343\u20131350. doi: 10.1056/NEJM200105033441801.", "ArticleIdList": ["10.1056/NEJM200105033441801", "11333990"]}, {"Citation": "F\u00e8ve B., Bastard J. P. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nature Reviews Endocrinology. 2009;5(6):305\u2013311. doi: 10.1038/nrendo.2009.62.", "ArticleIdList": ["10.1038/nrendo.2009.62", "19399017"]}, {"Citation": "Elmarakby A. A., Sullivan J. C. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovascular Therapeutics. 2012;30(1):49\u201359. doi: 10.1111/j.1755-5922.2010.00218.x.", "ArticleIdList": ["10.1111/j.1755-5922.2010.00218.x", "20718759"]}, {"Citation": "Aggarwal B. B., Gupta S. C., Kim J. H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012;119(3):651\u2013665. doi: 10.1182/blood-2011-04-325225.", "ArticleIdList": ["10.1182/blood-2011-04-325225", "PMC3265196", "22053109"]}, {"Citation": "Sprague A. H., Khalil R. A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochemical Pharmacology. 2009;78(6):539\u2013552. doi: 10.1016/j.bcp.2009.04.029.", "ArticleIdList": ["10.1016/j.bcp.2009.04.029", "PMC2730638", "19413999"]}, {"Citation": "Imai Y., Dobrian A. D., Weaver J. R., et al. Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease. Diabetes, Obesity and Metabolism. 2013;15(s3):117\u2013129. doi: 10.1111/dom.12161.", "ArticleIdList": ["10.1111/dom.12161", "PMC3777698", "24003928"]}, {"Citation": "Guilherme A., Virbasius J. V., Puri V., Czech M. P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell Biology. 2008;9(5):367\u2013377. doi: 10.1038/nrm2391.", "ArticleIdList": ["10.1038/nrm2391", "PMC2886982", "18401346"]}, {"Citation": "Olson A. L. Regulation of GLUT4 and insulin-dependent glucose flux. ISRN Molecular Biology. 2012;2012:12. doi: 10.5402/2012/856987.856987", "ArticleIdList": ["10.5402/2012/856987", "PMC4890881", "27335671"]}, {"Citation": "Akash M. S. H., Shen Q., Rehman K., Chen S. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. Journal of Pharmaceutical Sciences. 2012;101(5):1647\u20131658. doi: 10.1002/jps.23057.", "ArticleIdList": ["10.1002/jps.23057", "22271340"]}, {"Citation": "Akash M. S. H., Rehman K., Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. Journal of Cellular Biochemistry. 2013;114(3):525\u2013531. doi: 10.1002/jcb.24402.", "ArticleIdList": ["10.1002/jcb.24402", "22991242"]}, {"Citation": "Rehman K., Akash M. S. H. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? Journal of Biomedical Science. 2016;23(1, article 303):p. 87. doi: 10.1186/s12929-016-0303-y.", "ArticleIdList": ["10.1186/s12929-016-0303-y", "PMC5135788", "27912756"]}, {"Citation": "Swaroop J. J., Naidu J. N., Rajarajeswari D. Association of TNF-\u03b1 with insulin resistance in type 2 diabetes mellitus. The Indian Journal of Medical Research. 2012;135(1, article 93435):127\u2013130. doi: 10.4103/0971-5916.93435.", "ArticleIdList": ["10.4103/0971-5916.93435", "PMC3307173", "22382194"]}, {"Citation": "Hu G., Lindstr\u00f6m J., Valle T. T., et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Archives of Internal Medicine. 2004;164(8):p. 892. doi: 10.1001/archinte.164.8.892.", "ArticleIdList": ["10.1001/archinte.164.8.892", "15111376"]}, {"Citation": "Morohoshi M., Fujisawa K., Uchimuraa I., Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes. 1996;45(7):954\u2013959. doi: 10.2337/diab.45.7.954.", "ArticleIdList": ["10.2337/diab.45.7.954", "8666148"]}, {"Citation": "Iida K. T., Shimano H., Kawakami Y., et al. Insulin up-regulates tumor necrosis factor-\u03b1 production in macrophages through an extracellular-regulated kinase-dependent pathway. Journal of Biological Chemistry. 2001;276(35):32531\u201332537. doi: 10.1074/jbc.m009894200.", "ArticleIdList": ["10.1074/jbc.m009894200", "11443108"]}, {"Citation": "Chung H. Y., Kim H. J., Kim J. W., Yu B. P. The inflammation hypothesis of aging. Annals of the New York Academy of Sciences. 2001;928(1):327\u2013335. doi: 10.1111/j.1749-6632.2001.tb05662.x.", "ArticleIdList": ["10.1111/j.1749-6632.2001.tb05662.x", "11795524"]}, {"Citation": "Ye J. Mechanisms of insulin resistance in obesity. Frontiers of Medicine in China. 2013;7(1, article 262):14\u201324. doi: 10.1007/s11684-013-0262-6.", "ArticleIdList": ["10.1007/s11684-013-0262-6", "PMC3936017", "23471659"]}, {"Citation": "Koulmanda M., Bhasin M., Awdeh Z., et al. The role of TNF-\u03b1 in mice with type 1- and 2-diabetes. PLoS One. 2012;7(5):p. e33254. doi: 10.1371/journal.pone.0033254.", "ArticleIdList": ["10.1371/journal.pone.0033254", "PMC3350520", "22606220"]}, {"Citation": "Belwal T., Nabavi S., Nabavi S., Habtemariam S. Dietary anthocyanins and insulin resistance: when food becomes a medicine. Nutrients. 2017;9(10):p. 1111. doi: 10.3390/nu9101111.", "ArticleIdList": ["10.3390/nu9101111", "PMC5691727", "29023424"]}, {"Citation": "Hotamisligil G. S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nature Reviews Immunology. 2008;8(12):923\u2013934. doi: 10.1038/nri2449.", "ArticleIdList": ["10.1038/nri2449", "PMC2814543", "19029988"]}, {"Citation": "Solinas G., Karin M. JNK1 and IKK\u03b2: molecular links between obesity and metabolic dysfunction. FASEB Journal. 2010;24(8):2596\u20132611. doi: 10.1096/fj.09-151340.", "ArticleIdList": ["10.1096/fj.09-151340", "20371626"]}, {"Citation": "Baker R. G., Hayden M. S., Ghosh S. NF-\u03baB, inflammation, and metabolic disease. Cell Metabolism. 2011;13(1):11\u201322. doi: 10.1016/j.cmet.2010.12.008.", "ArticleIdList": ["10.1016/j.cmet.2010.12.008", "PMC3040418", "21195345"]}, {"Citation": "Prentki M., Nolan C. J. Islet cell failure in type 2 diabetes. Journal of Clinical Investigation. 2006;116(7):1802\u20131812. doi: 10.1172/JCI29103.", "ArticleIdList": ["10.1172/JCI29103", "PMC1483155", "16823478"]}, {"Citation": "Kim H., Lee M.-S. Role of innate immunity in triggering and tuning of autoimmune diabetes. Current Molecular Medicine. 2009;9(1):30\u201344. doi: 10.2174/156652409787314471.", "ArticleIdList": ["10.2174/156652409787314471", "19199940"]}, {"Citation": "Wrana J. L., Attisano L., Wieser R., Ventura F., Massagu\u00e9 J. Mechanism of activation of the TGF-\u03b2 receptor. Nature. 1994;370(6488):341\u2013347. doi: 10.1038/370341a0.", "ArticleIdList": ["10.1038/370341a0", "8047140"]}, {"Citation": "Wolf G., Ziyadeh F. N., Stahl R. A. K. Atrial natriuretic peptide stimulates the expression of transforming growth factor-beta in cultured murine mesangial cells: relationship to suppression of proliferation. Journal of the American Society of Nephrology. 1995;6:224\u2013233.", "ArticleIdList": ["7579089"]}, {"Citation": "Wolf G., Ziyadeh F. N., Zahner G., Stahl R. A. K. Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: attenuation after stable transfection with the c-mas oncogene. Kidney International. 1995;48(6):1818\u20131827. doi: 10.1038/ki.1995.480.", "ArticleIdList": ["10.1038/ki.1995.480", "8587241"]}, {"Citation": "Forbes J. M., Thallas V., Thomas M. C., et al. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. The FASEB Journal. 2003;17(12):1762\u20131764. doi: 10.1096/fj.02-1102fje.", "ArticleIdList": ["10.1096/fj.02-1102fje", "12958202"]}, {"Citation": "Sharma K., Jin Y., Guo J., Ziyadeh F. N. Neutralization of TGF-\u03b2 by anti-TGF-\u03b2 antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes. 1996;45(4):522\u2013530. doi: 10.2337/diab.45.4.522.", "ArticleIdList": ["10.2337/diab.45.4.522", "8603776"]}, {"Citation": "Ziyadeh F. N., Hoffman B. B., Han D. C., et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(14):8015\u20138020. doi: 10.1073/pnas.120055097.", "ArticleIdList": ["10.1073/pnas.120055097", "PMC16662", "10859350"]}, {"Citation": "Hill C., Flyvbjerg A., Rasch R., Bak M., Logan A. Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. Journal of Endocrinology. 2001;170(3):647\u2013651. doi: 10.1677/joe.0.1700647.", "ArticleIdList": ["10.1677/joe.0.1700647", "11524245"]}, {"Citation": "Hinerfeld D., Traini M. D., Weinberger R. P., et al. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. Journal of Neurochemistry. 2004;88(3):657\u2013667. doi: 10.1046/j.1471-4159.2003.02195.x.", "ArticleIdList": ["10.1046/j.1471-4159.2003.02195.x", "14720215"]}, {"Citation": "Wang B., Koh P., Winbanks C., et al. MiR-200a prevents renal fibrogenesis through repression of TGF-\u03b22 expression. Diabetes. 2010;60(1):280\u2013287. doi: 10.2337/db10-0892.", "ArticleIdList": ["10.2337/db10-0892", "PMC3012183", "20952520"]}, {"Citation": "Iwano M., Kubo A., Nishino T., et al. Quantification of glomerular TGF-\u03b21 mRNA in patients with diabetes mellitus. Kidney International. 1996;49(4):1120\u20131126. doi: 10.1038/ki.1996.162.", "ArticleIdList": ["10.1038/ki.1996.162", "8691733"]}, {"Citation": "Lizotte F., Denhez B., Guay A., G\u00e9vry N., C\u00f4t\u00e9 A. M., Geraldes P. Persistent insulin resistance in podocytes caused by epigenetic changes of SHP-1 in diabetes. Diabetes. 2016;65(12):3705\u20133717. doi: 10.2337/db16-0254.", "ArticleIdList": ["10.2337/db16-0254", "27585521"]}, {"Citation": "Dagher Z., Gerhardinger C., Vaz J., Goodridge M., Tecilazich F., Lorenzi M. The increased transforming growth factor-\u03b2 signaling induced by diabetes protects retinal vessels. The American Journal of Pathology. 2017;187(3):627\u2013638. doi: 10.1016/j.ajpath.2016.11.007.", "ArticleIdList": ["10.1016/j.ajpath.2016.11.007", "PMC5397667", "28162229"]}, {"Citation": "Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R. Diabetes mellitus, a microRNA-related disease? Translational Research. 2011;157(4):253\u2013264. doi: 10.1016/j.trsl.2011.01.009.", "ArticleIdList": ["10.1016/j.trsl.2011.01.009", "21420036"]}, {"Citation": "Cheng R., Dang R., Zhou Y., Ding M., Hua H. MicroRNA-98 inhibits TGF-\u03b21-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1. Human Cell. 2017;30(3, article 163):192\u2013200. doi: 10.1007/s13577-017-0163-0.", "ArticleIdList": ["10.1007/s13577-017-0163-0", "28251559"]}, {"Citation": "Ghosh A. K., Rai R., Flevaris P., Vaughan D. E. Epigenetics in reactive and reparative cardiac fibrogenesis: the promise of epigenetic therapy. Journal of Cellular Physiology. 2017;232(8):1941\u20131956. doi: 10.1002/jcp.25699.", "ArticleIdList": ["10.1002/jcp.25699", "27883184"]}, {"Citation": "Gustafson B. Adipose tissue, inflammation and atherosclerosis. Journal of Atherosclerosis and Thrombosis. 2010;17(4):332\u2013341. doi: 10.5551/jat.3939.", "ArticleIdList": ["10.5551/jat.3939", "20124732"]}, {"Citation": "Conde J., Scotece M., G\u00f3mez R., et al. Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. BioFactors. 2011;37(6):413\u2013420. doi: 10.1002/biof.185.", "ArticleIdList": ["10.1002/biof.185", "22038756"]}, {"Citation": "Tamura Y., Kawao N., Okada K., et al. Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice. Diabetes. 2013;62(9):3170\u20133179. doi: 10.2337/db12-1552.", "ArticleIdList": ["10.2337/db12-1552", "PMC3749344", "23715621"]}, {"Citation": "Ashcroft F. M., Rorsman P., Europe PMC Funders Group Diabetes mellitus and the \u03b2-cell: the last ten years. Cell. 2018;148(6):1160\u20131171.", "ArticleIdList": ["PMC5890906", "22424227"]}, {"Citation": "Okon E. B., Chung A. W. Y., Rauniyar P., et al. Compromised arterial function in human type 2 diabetic patients. Diabetes. 2005;54(8):2415\u20132423. doi: 10.2337/diabetes.54.8.2415.", "ArticleIdList": ["10.2337/diabetes.54.8.2415", "16046309"]}, {"Citation": "Gil L. T., Rosell\u00f3 A. M., Torres A. C., Moreno R. L., Orihuela J. A. F. Modulation of soluble phases of endothelial/leukocyte adhesion molecule 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 with interleukin-1\u03b2 after experimental endotoxic challenge. Critical Care Medicine. 2001;29(4):776\u2013781. doi: 10.1097/00003246-200104000-00018.", "ArticleIdList": ["10.1097/00003246-200104000-00018", "11373468"]}, {"Citation": "Noda K., Nakao S., Ishida S., Ishibashi T. Leukocyte adhesion molecules in diabetic retinopathy. Journal of Ophthalmology. 2012;2012:6. doi: 10.1155/2012/279037.279037", "ArticleIdList": ["10.1155/2012/279037", "PMC3216271", "22132315"]}, {"Citation": "Okada S., Shikata K., Matsuda M., et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes. 2003;52(10):2586\u20132593. doi: 10.2337/diabetes.52.10.2586.", "ArticleIdList": ["10.2337/diabetes.52.10.2586", "14514644"]}, {"Citation": "Chow F. Y., Nikolic-Paterson D. J., Ozols E., Atkins R. C., Tesch G. H. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. Journal of the American Society of Nephrology. 2005;16(6):1711\u20131722. doi: 10.1681/ASN.2004070612.", "ArticleIdList": ["10.1681/ASN.2004070612", "15857924"]}, {"Citation": "Miyamoto K., Khosrof S., Bursell S. E., et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proceedings of the National Academy of Sciences. 1999;96(19):10836\u201310841. doi: 10.1073/pnas.96.19.10836.", "ArticleIdList": ["10.1073/pnas.96.19.10836", "PMC17969", "10485912"]}, {"Citation": "Hirano Y., Sakurai E., Matsubara A., Ogura Y. Suppression of ICAM-1 in retinal and choroidal endothelial cells by plasmid small-interfering RNAs in vivo. Investigative Opthalmology & Visual Science. 2010;51(1):p. 508. doi: 10.1167/iovs.09-3457.", "ArticleIdList": ["10.1167/iovs.09-3457", "19578010"]}, {"Citation": "Leinonen E., Hurt-Camejo E., Wiklund O., Hult\u00e9n L. M., Hiukka A., Taskinen M. R. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis. 2003;166(2):387\u2013394. doi: 10.1016/S0021-9150(02)00371-4.", "ArticleIdList": ["10.1016/S0021-9150(02)00371-4", "12535753"]}, {"Citation": "Jude E. B., Abbott C. A., Young M. J., Anderson S. G., Douglas J. T., Boulton A. J. M. The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy. Diabetologia. 1998;41(3):330\u2013336. doi: 10.1007/s001250050911.", "ArticleIdList": ["10.1007/s001250050911", "9541174"]}, {"Citation": "Doupis J., Lyons T. E., Wu S., Gnardellis C., Dinh T., Veves A. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. The Journal of Clinical Endocrinology & Metabolism. 2009;94(6):2157\u20132163. doi: 10.1210/jc.2008-2385.", "ArticleIdList": ["10.1210/jc.2008-2385", "PMC2690431", "19276232"]}, {"Citation": "Spranger J., Kroke A., Mohlig M., et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003;52(3):812\u2013817. doi: 10.2337/diabetes.52.3.812.", "ArticleIdList": ["10.2337/diabetes.52.3.812", "12606524"]}, {"Citation": "Luotola K., P\u00e4\u00e4kk\u00f6nen R., Alanne M., et al. Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis. The Journal of Clinical Endocrinology & Metabolism. 2009;94(11):4575\u20134583. doi: 10.1210/jc.2009-0666.", "ArticleIdList": ["10.1210/jc.2009-0666", "19820020"]}, {"Citation": "Brown B. D., Nsengimana J., Barrett J. H., et al. An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study. BMC Medicine. 2010;8(1, article 264) doi: 10.1186/1741-7015-8-5.", "ArticleIdList": ["10.1186/1741-7015-8-5", "PMC2823655", "20070880"]}, {"Citation": "Stegger J. G., Schmidt E. B., Tj\u00f8nneland A., et al. Single nucleotide polymorphisms in IL1B and the risk of acute coronary syndrome: a Danish case-cohort study. PLoS ONE. 2012;7(6):p. e36829. doi: 10.1371/journal.pone.0036829.", "ArticleIdList": ["10.1371/journal.pone.0036829", "PMC3387186", "22768033"]}, {"Citation": "Tsimikas S., Duff G. W., Berger P. B., et al. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a) Journal of the American College of Cardiology. 2014;63(17):1724\u20131734. doi: 10.1016/j.jacc.2013.12.030.", "ArticleIdList": ["10.1016/j.jacc.2013.12.030", "PMC4008715", "24530664"]}, {"Citation": "Donath M. Y. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nature Reviews Drug Discovery. 2014;13(6):465\u2013476. doi: 10.1038/nrd4275.", "ArticleIdList": ["10.1038/nrd4275", "24854413"]}, {"Citation": "Gothai S., Ganesan P., Park S. Y., Fakurazi S., Choi D. K., Arulselvan P. Natural phyto-bioactive compounds for the treatment of type 2 diabetes: inflammation as a target. Nutrients. 2016;8(8):p. 461. doi: 10.3390/nu8080461.", "ArticleIdList": ["10.3390/nu8080461", "PMC4997374", "27527213"]}, {"Citation": "Anuradha C. V. Phytochemicals targeting genes relevant for type 2 diabetes. Canadian Journal of Physiology and Pharmacology. 2013;91(6):397\u2013411. doi: 10.1139/cjpp-2012-0350.", "ArticleIdList": ["10.1139/cjpp-2012-0350", "23745945"]}, {"Citation": "Kim S., Shin B. C., Lee M. S., Lee H., Ernst E. Red ginseng for type 2 diabetes mellitus: a systematic review of randomized controlled trials. Chinese Journal of Integrative Medicine. 2011;17(12):937\u2013944. doi: 10.1007/s11655-011-0937-2.", "ArticleIdList": ["10.1007/s11655-011-0937-2", "22139546"]}, {"Citation": "Priya Rani M., Padmakumari K. P., Sankarikutty B., Lijo Cherian O., Nisha V. M., Raghu K. G. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. International Journal of Food Sciences and Nutrition. 2011;62(2):106\u2013110. doi: 10.3109/09637486.2010.515565.", "ArticleIdList": ["10.3109/09637486.2010.515565", "20874376"]}, {"Citation": "Unuofin J. O., Otunola G. A., Afolayan A. J. In vitro \u03b1-amylase, \u03b1-glucosidase, lipase inhibitory and cytotoxic activities of tuber extracts of Kedrostis africana (L.) Cogn. Heliyon. 2018;4(9):p. e00810. doi: 10.1016/j.heliyon.2018.e00810.", "ArticleIdList": ["10.1016/j.heliyon.2018.e00810", "PMC6169336", "30294692"]}, {"Citation": "Yang L.-p., Sun H.-l., Wu L.-m., et al. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Investigative Opthalmology & Visual Science. 2009;50(5):p. 2319. doi: 10.1167/iovs.08-2642.", "ArticleIdList": ["10.1167/iovs.08-2642", "19011009"]}, {"Citation": "Ohno M., Shibata C., Kishikawa T., et al. The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice. Scientific Reports. 2013;3(1) doi: 10.1038/srep02553.", "ArticleIdList": ["10.1038/srep02553", "PMC3757358", "23989853"]}, {"Citation": "Ahad A., Mujeeb M., Ahsan H., Siddiqui W. A. Prophylactic effect of baicalein against renal dysfunction in type 2 diabetic rats. Biochimie. 2014;106:101\u2013110. doi: 10.1016/j.biochi.2014.08.006.", "ArticleIdList": ["10.1016/j.biochi.2014.08.006", "25151412"]}, {"Citation": "Prabhakar O. Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 2013;386(8, article 871):705\u2013710. doi: 10.1007/s00210-013-0871-2.", "ArticleIdList": ["10.1007/s00210-013-0871-2", "23612842"]}, {"Citation": "Guo R., Liu B., Wang K., Zhou S., Li W., Xu Y. Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-\u03baB pathway. Diabetes and Vascular Disease Research. 2014;11(2):92\u2013102. doi: 10.1177/1479164113520332.", "ArticleIdList": ["10.1177/1479164113520332", "24464099"]}, {"Citation": "Choi J., Yokozawa T., Oura H. Improvement of hyperglycemia and hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, prunin. Planta Medica. 1991;57(3):208\u2013211. doi: 10.1055/s-2006-960075.", "ArticleIdList": ["10.1055/s-2006-960075", "1896517"]}, {"Citation": "Tsai S.-J., Huang C.-S., Mong M.-C., Kam W.-Y., Huang H.-Y., Yin M.-C. Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice. Journal of Agricultural and Food Chemistry. 2012;60(1):514\u2013521. doi: 10.1021/jf203259h.", "ArticleIdList": ["10.1021/jf203259h", "22117528"]}, {"Citation": "Li J. J., Lee S. H., Kim D. K., et al. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. American Journal of Physiology-Renal Physiology. 2009;297(1):F200\u2013F209. doi: 10.1152/ajprenal.90649.2008.", "ArticleIdList": ["10.1152/ajprenal.90649.2008", "19369290"]}, {"Citation": "Ahad A., Ganai A. A., Mujeeb M., Siddiqui W. A. Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats. Toxicology and Applied Pharmacology. 2014;279(1):1\u20137. doi: 10.1016/j.taap.2014.05.007.", "ArticleIdList": ["10.1016/j.taap.2014.05.007", "24848621"]}, {"Citation": "Kumar B., Gupta S. K., Srinivasan B. P., et al. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvascular Research. 2013;87:65\u201374. doi: 10.1016/j.mvr.2013.01.002.", "ArticleIdList": ["10.1016/j.mvr.2013.01.002", "23376836"]}, {"Citation": "Chang C. L. T., Lin Y., Bartolome A. P., Chen Y. C., Chiu S. C., Yang W. C. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evidence-based Complementary and Alternative Medicine. 2013;2013:33. doi: 10.1155/2013/378657.", "ArticleIdList": ["10.1155/2013/378657", "PMC3638592", "23662132"]}, {"Citation": "Kim S., Jwa H., Yanagawa Y., Park T. Extract from Dioscorea batatas ameliorates insulin resistance in mice fed a high-fat diet. Journal of Medicinal Food. 2012;15(6):527\u2013534. doi: 10.1089/jmf.2011.2008.", "ArticleIdList": ["10.1089/jmf.2011.2008", "22424459"]}, {"Citation": "Liu M., Wu K., Mao X., Wu Y., Ouyang J. Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle. Journal of Ethnopharmacology. 2010;127(1):32\u201337. doi: 10.1016/j.jep.2009.09.055.", "ArticleIdList": ["10.1016/j.jep.2009.09.055", "19800959"]}, {"Citation": "Zhao M., Zhang Z. F., Ding Y., Wang J. B., Li Y. Astragalus polysaccharide improves palmitate-induced insulin resistance by inhibiting PTP1B and NF-\u03baB in C2C12 myotubes. Molecules. 2012;17(6):7083\u20137092. doi: 10.3390/molecules17067083.", "ArticleIdList": ["10.3390/molecules17067083", "PMC6268810", "22728372"]}, {"Citation": "Wu Y., Ou-Yang J. P., Wu K., Wang Y., Zhou Y. F., Wen C. Y. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B. Acta Pharmacologica Sinica. 2005;26(3):345\u2013352. doi: 10.1111/j.1745-7254.2005.00062.x.", "ArticleIdList": ["10.1111/j.1745-7254.2005.00062.x", "15715932"]}, {"Citation": "Mae T., Kishida H., Nishiyama T., et al. A licorice ethanolic extract with peroxisome proliferator-activated receptor-\u03b3 ligand-binding activity affects diabetes in KK-Ay mice, abdominal obesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats. The Journal of Nutrition. 2003;133(11):3369\u20133377. doi: 10.1093/jn/133.11.3369.", "ArticleIdList": ["10.1093/jn/133.11.3369", "14608046"]}, {"Citation": "Weidner C., de Groot J. C., Prasad A., et al. Amorfrutins are potent antidiabetic dietary natural products. Proceedings of the National Academy of Sciences. 2012;109(19):7257\u20137262. doi: 10.1073/pnas.1116971109.", "ArticleIdList": ["10.1073/pnas.1116971109", "PMC3358853", "22509006"]}, {"Citation": "Park S., Kim D. S., Kang S. Gastrodia elata Blume water extracts improve insulin resistance by decreasing body fat in diet-induced obese rats: vanillin and 4-hydroxybenzaldehyde are the bioactive candidates. European Journal of Nutrition. 2011;50(2):107\u2013118. doi: 10.1007/s00394-010-0120-0.", "ArticleIdList": ["10.1007/s00394-010-0120-0", "20577883"]}, {"Citation": "Qin B., Panickar K. S., Anderson R. A. Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. Journal of Diabetes Science and Technology. 2010;4(3):685\u2013693. doi: 10.1177/193229681000400324.", "ArticleIdList": ["10.1177/193229681000400324", "PMC2901047", "20513336"]}, {"Citation": "Rafehi H., Ververis K., Karagiannis T. C. Controversies surrounding the clinical potential of cinnamon for the management of diabetes. Diabetes, Obesity and Metabolism. 2012;14(6):493\u2013499. doi: 10.1111/j.1463-1326.2011.01538.x.", "ArticleIdList": ["10.1111/j.1463-1326.2011.01538.x", "22093965"]}, {"Citation": "Couturier K., Qin B., Batandier C., et al. Cinnamon increases liver glycogen in an animal model of insulin resistance. Metabolism. 2011;60(11):1590\u20131597. doi: 10.1016/j.metabol.2011.03.016.", "ArticleIdList": ["10.1016/j.metabol.2011.03.016", "21550075"]}, {"Citation": "Li J., Liu T., Wang L., et al. Antihyperglycemic and antihyperlipidemic action of cinnamaldehyde in C57BLKS/J db/db mice. Journal of Traditional Chinese Medicine. 2012;32(3):446\u2013452. doi: 10.1016/S0254-6272(13)60053-9.", "ArticleIdList": ["10.1016/S0254-6272(13)60053-9", "23297571"]}, {"Citation": "Valette G., Sauvaire Y., Baccou J., Ribes G. Hypocholesterolaemic effect of Fenugreek seeds in dogs. Atherosclerosis. 1984;50(1):105\u2013111. doi: 10.1016/0021-9150(84)90012-1.", "ArticleIdList": ["10.1016/0021-9150(84)90012-1", "6696779"]}, {"Citation": "Mohan V., Balasubramanyam M. Fenugreek and insulin resistance. The Journal of the Association of Physicians of India. 2001;49:1055\u20131056.", "ArticleIdList": ["11868854"]}, {"Citation": "Puri D., Prabhu K. M., Murthy P. S. Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Indian Journal of Physiology and Pharmacology. 2002;46(4):457\u2013462.", "ArticleIdList": ["12683221"]}, {"Citation": "Gupta A., Gupta R., Lal B. Effect of Trigonella foenum-graecum (Fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. Journal of the Association of Physicians of India. 2001;49:1057\u20131061.", "ArticleIdList": ["11868855"]}, {"Citation": "Guo J., Li L., Pan J., et al. Pharmacological mechanism of semen litchi on antagonizing insulin resistance in rats with type 2 diabetes. Journal of Chinese Medicinal Materials. 2004;27:435\u2013438.", "ArticleIdList": ["15524300"]}, {"Citation": "Zhang H., Teng Y. Effect of li ren (semen litchi) anti-diabetes pills in 45 cases of diabetes mellitus. Journal of Traditional Chinese Medicine. 1986;6(4):277\u2013278.", "ArticleIdList": ["3600021"]}, {"Citation": "Al-Romaiyan A., King A. J., Persaud S. J., Jones P. M. A novel extract of Gymnema sylvestre improves glucose tolerance in vivo and stimulates insulin secretion and synthesis in vitro. Phytotherapy Research. 2013;27(7):1006\u20131011. doi: 10.1002/ptr.4815.", "ArticleIdList": ["10.1002/ptr.4815", "22911568"]}, {"Citation": "Fujii M., Takei I., Umezawa K. Antidiabetic effect of orally administered conophylline-containing plant extract on streptozotocin-treated and Goto-Kakizaki rats. Biomedicine & Pharmacotherapy. 2009;63(10):710\u2013716. doi: 10.1016/j.biopha.2009.01.006.", "ArticleIdList": ["10.1016/j.biopha.2009.01.006", "19217246"]}, {"Citation": "Sabet F., Asgary S., Rahimi P., Mahzouni P., Madani H. Antidiabetic effect of hydroalcoholic extract of Carthamus tinctorius L. in alloxan-induced diabetic rats. Journal of Research in Medical Sciences. 2012;17:386\u2013392.", "ArticleIdList": ["PMC3526135", "23267403"]}, {"Citation": "Yun S. N., Moon S. J., Ko S. K., Im B. O., Chung S. H. Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Archives of Pharmacal Research. 2004;27(7):790\u2013796. doi: 10.1007/BF02980150.", "ArticleIdList": ["10.1007/BF02980150", "15357009"]}, {"Citation": "Yoo K. M., Lee C., Lo Y. M., Moon B. The hypoglycemic effects of American red ginseng (Panax quinquefolius L.) on a diabetic mouse model. Journal of Food Science. 2012;77(7):H147\u2013H152. doi: 10.1111/j.1750-3841.2012.02748.x.", "ArticleIdList": ["10.1111/j.1750-3841.2012.02748.x", "22757707"]}, {"Citation": "Lee H. J., Lee Y. H., Park S. K., et al. Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. Metabolism. 2009;58(8):1170\u20131177. doi: 10.1016/j.metabol.2009.03.015.", "ArticleIdList": ["10.1016/j.metabol.2009.03.015", "19477471"]}, {"Citation": "Chen F., Chen Y., Kang X., Zhou Z., Zhang Z., Liu D. Anti-apoptotic function and mechanism of ginseng saponins in Rattus pancreatic \u03b2-cells. Biological & Pharmaceutical Bulletin. 2012;35(9):1568\u20131573. doi: 10.1248/bpb.b12-00461.", "ArticleIdList": ["10.1248/bpb.b12-00461", "22975510"]}, {"Citation": "Kim H. Y., Kim K. Regulation of signaling molecules associated with insulin action, insulin secretion and pancreatic \u03b2-cell mass in the hypoglycemic effects of Korean red ginseng in Goto-Kakizaki rats. Journal of Ethnopharmacology. 2012;142(1):53\u201358. doi: 10.1016/j.jep.2012.04.012.", "ArticleIdList": ["10.1016/j.jep.2012.04.012", "22543177"]}, {"Citation": "Kim H. Y., Kim K. Protective effect of ginseng on cytokine-induced apoptosis in pancreatic \u03b2-cells. Journal of Agricultural and Food Chemistry. 2007;55(8):2816\u20132823. doi: 10.1021/jf062577r.", "ArticleIdList": ["10.1021/jf062577r", "17381103"]}, {"Citation": "Jong-Anurakkun N., Bhandari M. R., Hong G., Kawabata J. \u03b1-Glucosidase inhibitor from Chinese aloes. Fitoterapia. 2008;79(6):456\u2013457. doi: 10.1016/j.fitote.2008.02.010.", "ArticleIdList": ["10.1016/j.fitote.2008.02.010", "18508205"]}, {"Citation": "Lee J. H., Zhou H. Y., Cho S. Y., Kim Y. S., Lee Y. S., Jeong C. S. Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules. Archives of Pharmacal Research. 2007;30(10):1318\u20131327. doi: 10.1007/BF02980273.", "ArticleIdList": ["10.1007/BF02980273", "18038911"]}, {"Citation": "Bhathena S. J., Velasquez M. T. Beneficial role of dietary phytoestrogens in obesity and diabetes. The American Journal of Clinical Nutrition. 2002;76(6):1191\u20131201. doi: 10.1093/ajcn/76.6.1191.", "ArticleIdList": ["10.1093/ajcn/76.6.1191", "12450882"]}, {"Citation": "Lee Y. S., Kim W. S., Kim K. H., et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55(8):2256\u20132264. doi: 10.2337/db06-0006.", "ArticleIdList": ["10.2337/db06-0006", "16873688"]}, {"Citation": "Jeong H. W., Hsu K. C., Lee J. W., et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. American Journal of Physiology-Endocrinology and Metabolism. 2009;296(4):E955\u2013E964. doi: 10.1152/ajpendo.90599.2008.", "ArticleIdList": ["10.1152/ajpendo.90599.2008", "19208854"]}, {"Citation": "Chen C., Zhang Y., Huang C. Berberine inhibits PTP1B activity and mimics insulin action. Biochemical and Biophysical Research Communications. 2010;397(3):543\u2013547. doi: 10.1016/j.bbrc.2010.05.153.", "ArticleIdList": ["10.1016/j.bbrc.2010.05.153", "20515652"]}, {"Citation": "Yin J., Gao Z., Liu D., Liu Z., Ye J. Berberine improves glucose metabolism through induction of glycolysis. American Journal of Physiology-Endocrinology and Metabolism. 2008;294(1):E148\u2013E156. doi: 10.1152/ajpendo.00211.2007.", "ArticleIdList": ["10.1152/ajpendo.00211.2007", "PMC2464622", "17971514"]}, {"Citation": "Meng B., Li J., Cao H. Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. Current Pharmaceutical Design. 2013;19(11):2101\u20132113. doi: 10.2174/1381612811319110011.", "ArticleIdList": ["10.2174/1381612811319110011", "23116316"]}, {"Citation": "Chuengsamarn S., Rattanamongkolgul S., Luechapudiporn R., Phisalaphong C., Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012;35(11):2121\u20132127. doi: 10.2337/dc12-0116.", "ArticleIdList": ["10.2337/dc12-0116", "PMC3476912", "22773702"]}, {"Citation": "Wongeakin N., Bhattarakosol P., Patumraj S. Molecular mechanisms of curcumin on diabetes-induced endothelial dysfunctions: Txnip, ICAM-1, and NOX2 Expressions. BioMed Research International. 2014;2014:10. doi: 10.1155/2014/161346.161346", "ArticleIdList": ["10.1155/2014/161346", "PMC4098609", "25054130"]}, {"Citation": "Jain D., Bansal M. K., Dalvi R., Upganlawar A., Somani R. Protective effect of diosmin against diabetic neuropathy in experimental rats. Journal of Integrative Medicine. 2014;12(1):35\u201341. doi: 10.1016/S2095-4964(14)60001-7.", "ArticleIdList": ["10.1016/S2095-4964(14)60001-7", "24461593"]}, {"Citation": "Zhang X., Zhang R., Lv P., et al. Emodin up-regulates glucose metabolism, decreases lipolysis, and attenuates inflammation in vitro. Journal of Diabetes. 2015;7(3):360\u2013368. doi: 10.1111/1753-0407.12190.", "ArticleIdList": ["10.1111/1753-0407.12190", "24981886"]}, {"Citation": "Sabu M. C., Smitha K., Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. Journal of Ethnopharmacology. 2002;83(1-2):109\u2013116. doi: 10.1016/s0378-8741(02)00217-9.", "ArticleIdList": ["10.1016/s0378-8741(02)00217-9", "12413715"]}, {"Citation": "Iso H., Date C., Wakai K., Fukui M., Tamakoshi A., and the JACC Study Group The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Annals of Internal Medicine. 2006;144(8):554\u2013562. doi: 10.7326/0003-4819-144-8-200604180-00005.", "ArticleIdList": ["10.7326/0003-4819-144-8-200604180-00005", "16618952"]}, {"Citation": "Hayashino Y., Fukuhara S., Okamura T., Tanaka T., Ueshima H., for the HIPOP-OHP Research Group High oolong tea consumption predicts future risk of diabetes among Japanese male workers: a prospective cohort study. Diabetic Medicine. 2011;28(7):805\u2013810. doi: 10.1111/j.1464-5491.2011.03239.x.", "ArticleIdList": ["10.1111/j.1464-5491.2011.03239.x", "21244473"]}, {"Citation": "Orts\u00e4ter H., Grankvist N., Wolfram S., Kuehn N., Sj\u00f6holm \u00c5. Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutrition & Metabolism. 2012;9(1):p. 11. doi: 10.1186/1743-7075-9-11.", "ArticleIdList": ["10.1186/1743-7075-9-11", "PMC3298777", "22333133"]}, {"Citation": "Wolfram S., Raederstorff D., Preller M., et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. The Journal of Nutrition. 2006;136(10):2512\u20132518. doi: 10.1093/jn/136.10.2512.", "ArticleIdList": ["10.1093/jn/136.10.2512", "16988119"]}, {"Citation": "Fu Z., Zhang W., Zhen W., et al. Genistein induces pancreatic \u03b2-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology. 2010;151(7):3026\u20133037. doi: 10.1210/en.2009-1294.", "ArticleIdList": ["10.1210/en.2009-1294", "PMC2903942", "20484465"]}, {"Citation": "Fu Z., Gilbert E. R., Pfeiffer L., Zhang Y., Fu Y., Liu D. Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes. Applied Physiology, Nutrition, and Metabolism. 2012;37(3):480\u2013488. doi: 10.1139/h2012-005.", "ArticleIdList": ["10.1139/h2012-005", "PMC4337421", "22509809"]}, {"Citation": "Leiherer A., M\u00fcndlein A., Drexel H. Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascular Pharmacology. 2013;58(1-2):3\u201320. doi: 10.1016/j.vph.2012.09.002.", "ArticleIdList": ["10.1016/j.vph.2012.09.002", "22982056"]}, {"Citation": "Arunkumar E., Anuradha C. V. Genistein promotes insulin action through adenosine monophosphate-activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet. Nutrition Research. 2012;32(8):617\u2013625. doi: 10.1016/j.nutres.2012.06.002.", "ArticleIdList": ["10.1016/j.nutres.2012.06.002", "22935345"]}, {"Citation": "Chen A. Y., Chen Y. C. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chemistry. 2013;138(4):2099\u20132107. doi: 10.1016/j.foodchem.2012.11.139.", "ArticleIdList": ["10.1016/j.foodchem.2012.11.139", "PMC3601579", "23497863"]}, {"Citation": "Abo-Salem O. M. Kaempferol attenuates the development of diabetic neuropathic pain in mice: possible anti-inflammatory and anti-oxidant mechanisms. Open Access Macedonian Journal of Medical Sciences. 2014;2(3, article 424) doi: 10.3889/oamjms.2014.073.", "ArticleIdList": ["10.3889/oamjms.2014.073"]}, {"Citation": "Zang Y., Zhang L., Igarashi K., Yu C. The anti-obesity and anti-diabetic effects of kaempferol glycosides from unripe soybean leaves in high-fat-diet mice. Food Function. 2015;6(3):834\u2013841. doi: 10.1039/c4fo00844h.", "ArticleIdList": ["10.1039/c4fo00844h", "25599885"]}, {"Citation": "Abuohashish H. M., Al-Rejaie S. S., Al-Hosaini K. A., Parmar M. Y., Ahmed M. M. Alleviating effects of morin against experimentally-induced diabetic osteopenia. Diabetology & Metabolic Syndrome. 2013;5(1):p. 5. doi: 10.1186/1758-5996-5-5.", "ArticleIdList": ["10.1186/1758-5996-5-5", "PMC3582624", "23384060"]}, {"Citation": "Vanitha P., Uma C., Suganya N., et al. Modulatory effects of morin on hyperglycemia by attenuating the hepatic key enzymes of carbohydrate metabolism and \u03b2-cell function in streptozotocin- induced diabetic rats. Environmental Toxicology and Pharmacology. 2014;37(1):326\u2013335. doi: 10.1016/j.etap.2013.11.017.", "ArticleIdList": ["10.1016/j.etap.2013.11.017", "24384280"]}, {"Citation": "Tzeng T.-F., Liou S.-S., Liu I.-M. Myricetin ameliorates defective post-receptor insulin signaling via \u03b2-endorphin signaling in the skeletal muscles of fructose-fed rats. Evidence-Based Complementary and Alternative Medicine. 2011;2011:9. doi: 10.1093/ecam/neq017.neq017", "ArticleIdList": ["10.1093/ecam/neq017", "PMC3136182", "21785619"]}, {"Citation": "Chang C. J., Tzeng T. F., Liou S. S., Chang Y. S., Liu I. M. Myricetin increases hepatic peroxisome proliferator-activated receptor \u03b1 protein expression and decreases plasma lipids and adiposity in rats. Evidence-Based Complementary and Alternative Medicine. 2012;2012:11. doi: 10.1155/2012/787152.787152", "ArticleIdList": ["10.1155/2012/787152", "PMC3310287", "22474525"]}, {"Citation": "Sandeep M. S., Nandini C. D. Influence of quercetin, naringenin and berberine on glucose transporters and insulin signalling molecules in brain of streptozotocin-induced diabetic rats. Biomedicine & Pharmacotherapy. 2017;94:605\u2013611. doi: 10.1016/j.biopha.2017.07.142.", "ArticleIdList": ["10.1016/j.biopha.2017.07.142", "28783583"]}, {"Citation": "Pu P., Gao D. M., Mohamed S., et al. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Archives of Biochemistry and Biophysics. 2012;518(1):61\u201370. doi: 10.1016/j.abb.2011.11.026.", "ArticleIdList": ["10.1016/j.abb.2011.11.026", "22198281"]}, {"Citation": "Szkudelska K., Szkudelski T. Resveratrol, obesity and diabetes. European Journal of Pharmacology. 2010;635(1-3):1\u20138. doi: 10.1016/j.ejphar.2010.02.054.", "ArticleIdList": ["10.1016/j.ejphar.2010.02.054", "20303945"]}, {"Citation": "Do G. M., Jung U. J., Park H. J., et al. Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Molecular Nutrition & Food Research. 2012;56(8):1282\u20131291. doi: 10.1002/mnfr.201200067.", "ArticleIdList": ["10.1002/mnfr.201200067", "22715031"]}, {"Citation": "Mishra R., Sellin D., Radovan D., Gohlke A., Winter R. Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. ChemBioChem. 2009;10(3):445\u2013449. doi: 10.1002/cbic.200800762.", "ArticleIdList": ["10.1002/cbic.200800762", "19165839"]}, {"Citation": "Breen D. M., Sanli T., Giacca A., Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochemical and Biophysical Research Communications. 2008;374(1):117\u2013122. doi: 10.1016/j.bbrc.2008.06.104.", "ArticleIdList": ["10.1016/j.bbrc.2008.06.104", "18601907"]}, {"Citation": "Kar P., Laight D., Rooprai H. K., Shaw K. M., Cummings M. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabetic Medicine. 2009;26(5):526\u2013531. doi: 10.1111/j.1464-5491.2009.02727.x.", "ArticleIdList": ["10.1111/j.1464-5491.2009.02727.x", "19646193"]}, {"Citation": "Brasny\u00f3 P., Moln\u00e1r G. A., Moh\u00e1s M., et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. British Journal of Nutrition. 2011;106(3):383\u2013389. doi: 10.1017/S0007114511000316.", "ArticleIdList": ["10.1017/S0007114511000316", "21385509"]}, {"Citation": "Patil R. N., Patil R. Y., Ahirwar B., Ahirwar D. Evaluation of antidiabetic and related actions of some Indian medicinal plants in diabetic rats. Asian Pacific Journal of Tropical Medicine. 2011;4(1):20\u201323. doi: 10.1016/S1995-7645(11)60025-4.", "ArticleIdList": ["10.1016/S1995-7645(11)60025-4", "21771409"]}, {"Citation": "Hegazy G. A., Alnoury A. M., Gad H. G. The role of Acacia arabica extract as an antidiabetic, antihyperlipidemic, and antioxidant in streptozotocin-induced diabetic rats. Saudi Medical Journal. 2013;34(7):727\u2013733.", "ArticleIdList": ["23860893"]}, {"Citation": "Omara E. A., Nada S. A., Farrag A. R. H., Sharaf W. M., El-Toumy S. A. Therapeutic effect of Acacia nilotica pods extract on streptozotocin induced diabetic nephropathy in rat. Phytomedicine. 2012;19(12):1059\u20131067. doi: 10.1016/j.phymed.2012.07.006.", "ArticleIdList": ["10.1016/j.phymed.2012.07.006", "22884305"]}, {"Citation": "Geetha G., Kalavalarasariel Gopinathapillai P., Sankar V. Anti diabetic effect of Achyranthes rubrofusca leaf extracts on alloxan induced diabetic rats. Pakistan Journal of Pharmaceutical Sciences. 2011;24(2):193\u2013199.", "ArticleIdList": ["21454169"]}, {"Citation": "Ahmed D., Kumar V., Verma A., et al. Antidiabetic, renal/hepatic/pancreas/cardiac protective and antioxidant potential of methanol/dichloromethane extract of Albizzia lebbeck Benth. stem bark (ALEx) on streptozotocin induced diabetic rats. BMC Complementary and Alternative Medicine. 2014;14(1, article 1848) doi: 10.1186/1472-6882-14-243.", "ArticleIdList": ["10.1186/1472-6882-14-243", "PMC4223618", "25026962"]}, {"Citation": "Patel P., Parikh M., Johari S., Gandhi T. Antihyperglycemic activity of Albizzia lebbeck bark extract in streptozotocin-nicotinamide induced type II diabetes mellitus rats. AYU (An International Quarterly Journal of Research in Ayurveda) 2015;36(3):335\u2013340. doi: 10.4103/0974-8520.182752.", "ArticleIdList": ["10.4103/0974-8520.182752", "PMC4895763", "27313423"]}, {"Citation": "Kumar R., Sharma B., Tomar N. R., Roy P., Gupta A. K., Kumar A. In vivo evaluation of hypoglycemic activity of Aloe spp. and identification of its mode of action on GLUT-4 gene expression in vitro. Applied Biochemistry and Biotechnology. 2011;164(8):1246\u20131256. doi: 10.1007/s12010-011-9210-6.", "ArticleIdList": ["10.1007/s12010-011-9210-6", "21409411"]}, {"Citation": "Noor A., Gunasekaran S., Soosai Manickam A., Vijayalakshmi M. A. Antidiabetic activity of Aloe vera and histology of organs in streptozotocin-induced diabetic rats. Current Science. 2008;94:1070\u20131076."}, {"Citation": "Manjunath K., Bhanu G., Subash K. R., Tadvi N. A., Manikanta M., Umamaheswara K. Effect of Aloe vera leaf extract on blood glucose levels in alloxan induced diabetic rats. National Journal of Physiology, Pharmacy and Pharmacology. 2016;6(5):p. 471. doi: 10.5455/njppp.2016.6.0718613072016.", "ArticleIdList": ["10.5455/njppp.2016.6.0718613072016"]}, {"Citation": "Afolayan A. J., Sunmonu T. O. Artemisia afra Jacq. ameliorates oxidative stress in the pancreas of streptozotocin-induced diabetic Wistar rats. Bioscience, Biotechnology, and Biochemistry. 2011;75(11):2083\u20132086. doi: 10.1271/bbb.100792.", "ArticleIdList": ["10.1271/bbb.100792", "22056428"]}, {"Citation": "Dheer R., Bhatnagar P. A study of the antidiabetic activity of Barleria prionitis Linn. Indian Journal of Pharmacology. 2010;42(2):69\u201373. doi: 10.4103/0253-7613.64493.", "ArticleIdList": ["10.4103/0253-7613.64493", "PMC2907017", "20711368"]}, {"Citation": "Pari L., Amarnath Satheesh M. Antidiabetic effect of Boerhavia diffusa: effect on serum and tissue lipids in experimental diabetes. Journal of Medicinal Food. 2004;7(4):472\u2013476. doi: 10.1089/jmf.2004.7.472.", "ArticleIdList": ["10.1089/jmf.2004.7.472", "15671692"]}, {"Citation": "Baquer N. Z., Gupta D., Raju J. Regulation of metabolic pathways in liver and kidney during experimental diabetes: effects of antidiabetic compounds. Indian Journal of Clinical Biochemistry. 1998;13(2):63\u201380. doi: 10.1007/BF02867866.", "ArticleIdList": ["10.1007/BF02867866", "PMC3453566", "23105185"]}, {"Citation": "Bhat M., Zinjarde S. S., Bhargava S. Y., Kumar A. R., Joshi B. N. Antidiabetic Indian plants: a good source of potent amylase inhibitors. Evidence-Based Complementary and Alternative Medicine. 2011;2011:6. doi: 10.1093/ecam/nen040.nen040", "ArticleIdList": ["10.1093/ecam/nen040", "PMC3137644", "18955350"]}, {"Citation": "Geethan P. K. M. A., Prince P. S. M. Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic Wistar rats. Journal of Biochemical and Molecular Toxicology. 2008;22(4):220\u2013224. doi: 10.1002/jbt.20218.", "ArticleIdList": ["10.1002/jbt.20218", "18752266"]}, {"Citation": "Perez-Gutierrez R. M., Mu\u00f1iz-Ramirez A., Gomez Y. G., Ram\u00edrez E. B. Antihyperglycemic, antihyperlipidemic and antiglycation effects of Byrsonima crassifolia fruit and seed in normal and streptozotocin-induced diabetic rats. Plant Foods for Human Nutrition. 2010;65(4):350\u2013357. doi: 10.1007/s11130-010-0181-5.", "ArticleIdList": ["10.1007/s11130-010-0181-5", "20734144"]}, {"Citation": "Vasconcelos C. F. B., Maranh\u00e3o H. M. L., Batista T. M., et al. Hypoglycaemic activity and molecular mechanisms of Caesalpinia ferrea Martius bark extract on streptozotocin-induced diabetes in Wistar rats. Journal of Ethnopharmacology. 2011;137(3):1533\u20131541. doi: 10.1016/j.jep.2011.08.059.", "ArticleIdList": ["10.1016/j.jep.2011.08.059", "21911047"]}, {"Citation": "Prakasam A., Sethupathy S., Pugalendi K. V. Influence of Casearia esculenta root extract on protein metabolism and marker enzymes in streptozotocin-induced diabetic rats. Polish Journal of Pharmacology. 2004;56:587\u2013593.", "ArticleIdList": ["15591647"]}, {"Citation": "Agnihotri A., Singh V. Effect of Tamarindus indica Linn. and Cassia fistula Linn. stem bark extracts on oxidative stress and diabetic conditions. Acta Poloniae Pharmaceutica. 2013;70(6):1011\u20131019.", "ArticleIdList": ["24383324"]}, {"Citation": "Singh S. N., Vats P., Suri S., et al. Effect of an antidiabetic extract of Catharanthus roseus on enzymic activities in streptozotocin induced diabetic rats. Journal of Ethnopharmacology. 2001;76(3):269\u2013277. doi: 10.1016/S0378-8741(01)00254-9.", "ArticleIdList": ["10.1016/S0378-8741(01)00254-9", "11448549"]}, {"Citation": "Nabeel M. A., Kathiresan K., Manivannan S. Antidiabetic activity of the mangrove species Ceriops decandra in alloxan-induced diabetic rats. Journal of Diabetes. 2010;2(2):97\u2013103. doi: 10.1111/j.1753-0407.2010.00068.x.", "ArticleIdList": ["10.1111/j.1753-0407.2010.00068.x", "20923491"]}, {"Citation": "Orhan N., Aslan M., \u015e\u00fck\u00fcro\u01e7lu M., Deliorman Orhan D. In vivo and in vitro antidiabetic effect of Cistus laurifolius L. and detection of major phenolic compounds by UPLC-TOF-MS analysis. Journal of Ethnopharmacology. 2013;146(3):859\u2013865. doi: 10.1016/j.jep.2013.02.016.", "ArticleIdList": ["10.1016/j.jep.2013.02.016", "23462413"]}, {"Citation": "Agarwal V., Sharma A. K., Upadhyay A., Singh G., Gupta R. Hypoglycemic effects of Citrullus colocynthis roots. Acta Poloniae Pharmaceutica. 2012;69:75\u201379.", "ArticleIdList": ["22574509"]}, {"Citation": "Dechandt C. R. P., Siqueira J. T., de Souza D. L. P., et al. Combretum lanceolatum flowers extract shows antidiabetic activity through activation of AMPK by quercetin. Revista Brasileira de Farmacognosia. 2013;23(2):291\u2013300. doi: 10.1590/s0102-695x2012005000140.", "ArticleIdList": ["10.1590/s0102-695x2012005000140"]}, {"Citation": "Nain P., Saini V., Sharma S., Nain J. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. Journal of Ethnopharmacology. 2012;142(1):65\u201371. doi: 10.1016/j.jep.2012.04.014.", "ArticleIdList": ["10.1016/j.jep.2012.04.014", "22855943"]}, {"Citation": "Hassan Z., Yam M. F., Ahmad M., Yusof A. P. M. Antidiabetic properties and mechanism of action of Gynura procumbens water extract in streptozotocin-induced diabetic rats. Molecules. 2010;15(12):9008\u20139023. doi: 10.3390/molecules15129008.", "ArticleIdList": ["10.3390/molecules15129008", "PMC6259173", "21150821"]}, {"Citation": "Venkatesh S., Reddy B. M., Reddy G. D., Mullangi R., Lakshman M. Antihyperglycemic and hypolipidemic effects of Helicteres isora roots in alloxan-induced diabetic rats: a possible mechanism of action. Journal of Natural Medicines. 2010;64(3):295\u2013304. doi: 10.1007/s11418-010-0406-9.", "ArticleIdList": ["10.1007/s11418-010-0406-9", "20238178"]}, {"Citation": "Maheshwari P., Baburao B., Pradeep Kumar C., Reddy A. R. N. Antidiabetic activity of methanolic extract of Hiptage bengalensis leaves in alloxan induced diabetic models. Pakistan Journal of Biological Sciences. 2013;16(17):844\u2013851. doi: 10.3923/pjbs.2013.844.851.", "ArticleIdList": ["10.3923/pjbs.2013.844.851", "24498837"]}, {"Citation": "Mishra S. B., Verma A., Mukerjee A., Vijayakumar M. Anti-hyperglycemic activity of leaves extract of Hyptis suaveolens L. Poit in streptozotocin induced diabetic rats. Asian Pacific Journal of Tropical Medicine. 2011;4(9):689\u2013693. doi: 10.1016/S1995-7645(11)60175-2.", "ArticleIdList": ["10.1016/S1995-7645(11)60175-2", "21967690"]}, {"Citation": "Kumar S., Kumar V., Prakash O. M. Antidiabetic and hypolipidemic activities of Kigelia pinnata flowers extract in streptozotocin induced diabetic rats. Asian Pacific Journal of Tropical Biomedicine. 2012;2(7):543\u2013546. doi: 10.1016/s2221-1691(12)60093-8.", "ArticleIdList": ["10.1016/s2221-1691(12)60093-8", "PMC3609338", "23569967"]}, {"Citation": "Ma C., Yu H., Xiao Y., Wang H. Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats. Pharmaceutical Biology. 2017;55(1):2170\u20132177. doi: 10.1080/13880209.2017.1396350.", "ArticleIdList": ["10.1080/13880209.2017.1396350", "PMC6130557", "29110587"]}, {"Citation": "Kesari A. N., Gupta R. K., Watal G. Hypoglycemic effects of Murraya koenigii on normal and alloxan-diabetic rabbits. Journal of Ethnopharmacology. 2005;97(2):247\u2013251. doi: 10.1016/j.jep.2004.11.006.", "ArticleIdList": ["10.1016/j.jep.2004.11.006", "15707761"]}, {"Citation": "Saba A. B., Oyagbemi A. A., Azeez O. I. Antidiabetic and haematinic effects of Parquetina nigrescens on alloxan induced type-1 diabetes and normocytic normochromic anaemia in Wistar rats. African Health Sciences. 2010;10", "ArticleIdList": ["PMC3035967", "21327140"]}, {"Citation": "Mard S. A., Jalalvand K., Jafarinejad M., Balochi H., Naseri M. K. G. Evaluation of the antidiabetic and antilipaemic activities of the hydroalcoholic extract of Phoenix dactylifera palm leaves and its fractions in alloxan-induced diabetic rats. The Malaysian Journal of Medical Sciences. 2010;17:4\u201313.", "ArticleIdList": ["PMC3216186", "22135555"]}, {"Citation": "Okoli C. O., Ibiam A. F., Ezike A. C., Akah P. A., Okoye T. C. Evaluation of antidiabetic potentials of Phyllanthus niruri in alloxan diabetic rats. African Journal of Biotechnology. 2010;9"}, {"Citation": "Tamrakar A. K., Jaiswal N., Yadav P. P., Maurya R., Srivastava A. K. Pongamol from Pongamia pinnata stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells. Molecular and Cellular Endocrinology. 2011;339(1-2):98\u2013104. doi: 10.1016/j.mce.2011.03.023.", "ArticleIdList": ["10.1016/j.mce.2011.03.023", "21497640"]}, {"Citation": "Goli V., Kanakam V., Macharala S., Gowrishankar N. L., Jimmidi B., Dhanalakshmi C. H. Antidiabetic activity of Pongamia pinnata flower extracts on alloxan induced diabetic rats. Journal of Global Pharma Technology. 2012;4(2):13\u201317."}, {"Citation": "Huang C. S., Yin M. C., Chiu L. C. Antihyperglycemic and antioxidative potential of Psidium guajava fruit in streptozotocin-induced diabetic rats. Food and Chemical Toxicology. 2011;49(9):2189\u20132195. doi: 10.1016/j.fct.2011.05.032.", "ArticleIdList": ["10.1016/j.fct.2011.05.032", "21679740"]}, {"Citation": "Kaur G., Kamboj P., Kalia A. N. Antidiabetic and anti-hypercholesterolemic effects of aerial parts of Sida cordifolia Linn. on streptozotocin-induced diabetic rats. Indian Journal of Natural Products and Resources. 2011;2:428\u2013434."}, {"Citation": "Prabhu K. S., Lobo R., Shirwaikar A. Antidiabetic properties of the alcoholic extract of Sphaeranthus indicus in streptozotocin-nicotinamide diabetic rats. Journal of Pharmacy and Pharmacology. 2008;60(7):909\u2013916. doi: 10.1211/jpp.60.7.0013.", "ArticleIdList": ["10.1211/jpp.60.7.0013", "18549678"]}, {"Citation": "Latha R. C. R., Daisy P. Therapeutic potential of octyl gallate isolated from fruits of Terminalia bellerica in streptozotocin-induced diabetic rats. Pharmaceutical Biology. 2013;51(6):798\u2013805. doi: 10.3109/13880209.2013.766894.", "ArticleIdList": ["10.3109/13880209.2013.766894", "23675839"]}, {"Citation": "Rao N. K., Nammi S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complementary and Alternative Medicine. 2006;6(1, article 91) doi: 10.1186/1472-6882-6-17.", "ArticleIdList": ["10.1186/1472-6882-6-17", "PMC1540439", "16677399"]}, {"Citation": "Mowl A., Alauddin M., Rahman M., Ahmed K. Antihyperglycemic effect of Trigonella foenum-graecum (fenugreek) seed extract in alloxan-induced diabetic rats and its use in diabetes mellitus: a brief qualitative phytochemical and acute toxicity test on the extract. African Journal of Traditional, Complementary and Alternative Medicines. 2010;6(3) doi: 10.4314/ajtcam.v6i3.57165.", "ArticleIdList": ["10.4314/ajtcam.v6i3.57165", "PMC2816457", "20448850"]}, {"Citation": "Meenakshi P., Bhuvaneshwari R., Rathi M. A., et al. Antidiabetic activity of ethanolic extract of Zaleya decandra in alloxan-induced diabetic rats. Applied Biochemistry and Biotechnology. 2010;162(4, article 8871):1153\u20131159. doi: 10.1007/s12010-009-8871-x.", "ArticleIdList": ["10.1007/s12010-009-8871-x", "19957208"]}, {"Citation": "Martineau L. C., Couture A., Spoor D., et al. Anti-diabetic properties of the Canadian lowbush blueberry Vaccinium angustifolium Ait. Phytomedicine. 2006;13(9-10):612\u2013623. doi: 10.1016/j.phymed.2006.08.005.", "ArticleIdList": ["10.1016/j.phymed.2006.08.005", "16979328"]}, {"Citation": "Inaguma T., Han J., Isoda H. Improvement of insulin resistance by Cyanidin 3-glucoside, anthocyanin from black beans through the up-regulation of GLUT4 gene expression. BMC Proceedings. 2011;5(Supplement 8):p. P21. doi: 10.1186/1753-6561-5-s8-p21.", "ArticleIdList": ["10.1186/1753-6561-5-s8-p21", "PMC3284935", "22373152"]}, {"Citation": "Ueda M., Furuyashiki T., Yamada K., et al. Tea catechins modulate the glucose transport system in 3T3-L1 adipocytes. Food & Function. 2010;1(2):167\u2013173. doi: 10.1039/c0fo00105h.", "ArticleIdList": ["10.1039/c0fo00105h", "21776468"]}, {"Citation": "Yan J., Zhao Y., Suo S., Liu Y., Zhao B. Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. Free Radical Biology and Medicine. 2012;52(9):1648\u20131657. doi: 10.1016/j.freeradbiomed.2012.01.033.", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.01.033", "22330066"]}, {"Citation": "Asano K., Takagi K., Haneishi A., Nakamura S., Yamada K. (\u2212)-Epigallocatechin-3-gallate stimulates both AMP-activated protein kinase and nuclear factor-kappa B signaling pathways. Food Chemistry. 2012;134(2):783\u2013788. doi: 10.1016/j.foodchem.2012.02.181.", "ArticleIdList": ["10.1016/j.foodchem.2012.02.181", "23107691"]}, {"Citation": "Ueda M., Nishiumi S., Nagayasu H., Fukuda I., Yoshida K.-i., Ashida H. Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle. Biochemical and Biophysical Research Communications. 2008;377(1):286\u2013290. doi: 10.1016/j.bbrc.2008.09.128.", "ArticleIdList": ["10.1016/j.bbrc.2008.09.128", "18845128"]}, {"Citation": "Lin C. L., Lin J. K. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Molecular Nutrition & Food Research. 2008;52(8):930\u2013939. doi: 10.1002/mnfr.200700437.", "ArticleIdList": ["10.1002/mnfr.200700437", "18496818"]}, {"Citation": "Murase T., Misawa K., Haramizu S., Hase T. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochemical Pharmacology. 2009;78(1):78\u201384. doi: 10.1016/j.bcp.2009.03.021.", "ArticleIdList": ["10.1016/j.bcp.2009.03.021", "19447226"]}, {"Citation": "Zhang Z. F., Li Q., Liang J., et al. Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine. 2010;17(1):14\u201318. doi: 10.1016/j.phymed.2009.09.007.", "ArticleIdList": ["10.1016/j.phymed.2009.09.007", "19819682"]}, {"Citation": "Zygmunt K., Faubert B., MacNeil J., Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochemical and Biophysical Research Communications. 2010;398(2):178\u2013183. doi: 10.1016/j.bbrc.2010.06.048.", "ArticleIdList": ["10.1016/j.bbrc.2010.06.048", "20558145"]}, {"Citation": "Cazarolli L. H., Folador P., Moresco H. H., Brighente I. M. C., Pizzolatti M. G., Silva F. R. M. B. Stimulatory effect of apigenin-6-C-\u03b2-l-fucopyranoside on insulin secretion and glycogen synthesis. European Journal of Medicinal Chemistry. 2009;44(11):4668\u20134673. doi: 10.1016/j.ejmech.2009.07.001.", "ArticleIdList": ["10.1016/j.ejmech.2009.07.001", "19625113"]}, {"Citation": "Kim M. S., Hur H. J., Kwon D. Y., Hwang J. T. Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice. Molecular and Cellular Endocrinology. 2012;358(1):127\u2013134. doi: 10.1016/j.mce.2012.03.013.", "ArticleIdList": ["10.1016/j.mce.2012.03.013", "22476082"]}, {"Citation": "Onda K., Horike N., Suzuki T. I., Hirano T. Polymethoxyflavonoids tangeretin and nobiletin increase glucose uptake in murine adipocytes. Phytotherapy Research. 2013;27(2):312\u2013316. doi: 10.1002/ptr.4730.", "ArticleIdList": ["10.1002/ptr.4730", "22585555"]}, {"Citation": "Cazarolli L. H., Pereira D. F., Kappel V. D., et al. Insulin signaling: a potential signaling pathway for the stimulatory effect of kaempferitrin on glucose uptake in skeletal muscle. European Journal of Pharmacology. 2013;712(1-3):1\u20137. doi: 10.1016/j.ejphar.2013.02.029.", "ArticleIdList": ["10.1016/j.ejphar.2013.02.029", "23458067"]}, {"Citation": "Fang X. K., Gao J., Zhu D. N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sciences. 2008;82(11-12):615\u2013622. doi: 10.1016/j.lfs.2007.12.021.", "ArticleIdList": ["10.1016/j.lfs.2007.12.021", "18262572"]}, {"Citation": "Cazarolli L. H., Folador P., Pizzolatti M. G., Silva F. R. M. B. Signaling pathways of kaempferol-3-neohesperidoside in glycogen synthesis in rat soleus muscle. Biochimie. 2009;91(7):843\u2013849. doi: 10.1016/j.biochi.2009.04.004.", "ArticleIdList": ["10.1016/j.biochi.2009.04.004", "19376191"]}, {"Citation": "Paoli P., Cirri P., Caselli A., et al. The insulin-mimetic effect of Morin: a promising molecule in diabetes treatment. Biochimica et Biophysica Acta (BBA) - General Subjects. 2013;1830(4):3102\u20133111. doi: 10.1016/j.bbagen.2013.01.017.", "ArticleIdList": ["10.1016/j.bbagen.2013.01.017", "23352912"]}, {"Citation": "Matsuda H., Kogami Y., Nakamura S., Sugiyama T., Ueno T., Yoshikawa M. Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells. Bioorganic & Medicinal Chemistry. 2011;19(9):2835\u20132841. doi: 10.1016/j.bmc.2011.03.040.", "ArticleIdList": ["10.1016/j.bmc.2011.03.040", "21493073"]}, {"Citation": "Lee M. S., Kim C. H., Hoang D. M., et al. Genistein-derivatives from Tetracera scandens stimulate glucose-uptake in L6 myotubes. Biological & Pharmaceutical Bulletin. 2009;32(3):504\u2013508. doi: 10.1248/bpb.32.504.", "ArticleIdList": ["10.1248/bpb.32.504", "19252305"]}, {"Citation": "Sai K. S., Srividya N. Blood glucose lowering effect of the leaves of Tinospora cordifolia and Sauropus androgynus in diabetic subjects. Journal of Natural Remedies. 2002;2:28\u201332."}, {"Citation": "Salehi. Antidiabetic potential of medicinal plants and their active components. Biomolecules. 2019;9(10):p. 551. doi: 10.3390/biom9100551.", "ArticleIdList": ["10.3390/biom9100551", "PMC6843349", "31575072"]}, {"Citation": "Singh S., Gupta S. K., Sabir G., Gupta M. K., Seth P. K. A database for anti-diabetic plants with clinical/ experimental trials. Bioinformation. 2009;4(6):263\u2013268. doi: 10.6026/97320630004263.", "ArticleIdList": ["10.6026/97320630004263", "PMC2951713", "20975921"]}, {"Citation": "El-Demerdash F. M., Yousef M. I., El-Naga N. I. A. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan- induced diabetic rats. Food and Chemical Toxicology. 2005;43(1):57\u201363. doi: 10.1016/j.fct.2004.08.012.", "ArticleIdList": ["10.1016/j.fct.2004.08.012", "15582196"]}, {"Citation": "Azuma K., Minami Y., Ippoushi K., Terao J. Lowering effects of onion intake on oxidative stress biomarkers in streptozotocin-induced diabetic rats. Journal of Clinical Biochemistry and Nutrition. 2007;40(2):131\u2013140. doi: 10.3164/jcbn.40.131.", "ArticleIdList": ["10.3164/jcbn.40.131", "PMC2127222", "18188415"]}, {"Citation": "El-Soud N. A., Khalil M. Antioxidative effects of Allium cepa essential oil in streptozotocin induced diabetic rats. Macedonian Journal of Medical Sciences. 2010;1(1):1\u20138. doi: 10.3889/MJMS.1857-5773.2010.0118.", "ArticleIdList": ["10.3889/MJMS.1857-5773.2010.0118"]}, {"Citation": "Ogunmodede O. S., Saalu L. C., Ogunlade B., Akunna G. G., Oyewopo A. O. An evaluation of the hypoglycemic, antioxidant and hepatoprotective potentials of onion (Allium cepa L.) on alloxan-induced diabetic rabbits. International Journal of Pharmacology. 2012;8(1):21\u201329. doi: 10.3923/ijp.2012.21.29.", "ArticleIdList": ["10.3923/ijp.2012.21.29"]}, {"Citation": "Akash M. S. H., Rehman K., Chen S. Spice plant Allium cepa: dietary supplement for treatment of type 2 diabetes mellitus. Nutrition. 2014;30(10):1128\u20131137. doi: 10.1016/j.nut.2014.02.011.", "ArticleIdList": ["10.1016/j.nut.2014.02.011", "25194613"]}, {"Citation": "Governa P., Baini G., Borgonetti V., et al. Phytotherapy in the management of diabetes: a review. Molecules. 2018;23(1):105\u2013122. doi: 10.3390/molecules23010105.", "ArticleIdList": ["10.3390/molecules23010105", "PMC6017385", "29300317"]}, {"Citation": "Eldin I. M. T., Ahmed E. M., Abd E. H. M. Preliminary study of the clinical hypoglycemic effects of Allium cepa (red onion) in type 1 and type 2 diabetic patients. Environmental Health Insights. 2010;4 doi: 10.4137/ehi.s5540.", "ArticleIdList": ["10.4137/ehi.s5540", "PMC2978938", "21079693"]}, {"Citation": "Bunyapraphatsara N., Yongchaiyudha S., Rungpitarangsi V., Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine. 1996;3(3):245\u2013248. doi: 10.1016/S0944-7113(96)80061-4.", "ArticleIdList": ["10.1016/S0944-7113(96)80061-4", "23195078"]}, {"Citation": "Choi H.-C., Kim S.-J., Son K.-Y., Oh B.-J., Cho B.-L. Metabolic effects of Aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: randomized controlled trial. Nutrition. 2013;29(9):1110\u20131114. doi: 10.1016/j.nut.2013.02.015.", "ArticleIdList": ["10.1016/j.nut.2013.02.015", "23735317"]}, {"Citation": "Modak M., Dixit P., Londhe J., Ghaskadbi S., Devasagayam T. P. A. Indian herbs and herbal drugs used for the treatment of diabetes. Journal of Clinical Biochemistry and Nutrition. 2007;40(3):163\u2013173. doi: 10.3164/jcbn.40.163.", "ArticleIdList": ["10.3164/jcbn.40.163", "PMC2275761", "18398493"]}, {"Citation": "Khan A., Bryden N. A., Polansky M. M., Anderson R. A. Insulin potentiating factor and chromium content of selected foods and spices. Biological Trace Element Research. 1990;24(2-3):183\u2013188. doi: 10.1007/BF02917206.", "ArticleIdList": ["10.1007/BF02917206", "1702671"]}, {"Citation": "Sartorius T., Peter A., Schulz N., et al. Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity. PLoS One. 2014;9(3) doi: 10.1371/journal.pone.0092358.", "ArticleIdList": ["10.1371/journal.pone.0092358", "PMC3958529", "24643026"]}, {"Citation": "Kirkham S., Akilen R., Sharma S., Tsiami A. The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obesity and Metabolism. 2009;11(12):1100\u20131113. doi: 10.1111/j.1463-1326.2009.01094.x.", "ArticleIdList": ["10.1111/j.1463-1326.2009.01094.x", "19930003"]}, {"Citation": "Hasanzade F., Toliat M., Emami S. A., Emamimoghaadam Z. The effect of cinnamon on glucose of type II diabetes patients. Journal of Traditional and Complementary Medicine. 2013;3(3):171\u2013174. doi: 10.4103/2225-4110.114900.", "ArticleIdList": ["10.4103/2225-4110.114900", "PMC3924990", "24716174"]}, {"Citation": "Mang B., Wolters M., Schmitt B., et al. Effects of a cinnamon extract on plasma glucose, HbA1c, and serum lipids in diabetes mellitus type 2. European Journal of Clinical Investigation. 2006;36(5):340\u2013344. doi: 10.1111/j.1365-2362.2006.01629.x.", "ArticleIdList": ["10.1111/j.1365-2362.2006.01629.x", "16634838"]}, {"Citation": "Gutierrez J. L., Bowden R. G., Willoughby D. S. Cassia cinnamon supplementation reduces peak blood glucose responses but does not improve insulin resistance and sensitivity in young, sedentary, obese women. Journal of Dietary Supplements. 2016;13(4):461\u2013471. doi: 10.3109/19390211.2015.1110222.", "ArticleIdList": ["10.3109/19390211.2015.1110222", "26716656"]}, {"Citation": "Altschuler J. A., Casella S. J., MacKenzie T. A., Curtis K. M. The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care. 2007;30(4):813\u2013816. doi: 10.2337/dc06-1871.", "ArticleIdList": ["10.2337/dc06-1871", "17392542"]}, {"Citation": "Hosseini S., Jamshidi L., Mehrzadi S., et al. Effects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial. Journal of Ethnopharmacology. 2014;152(3):451\u2013456. doi: 10.1016/j.jep.2014.01.012.", "ArticleIdList": ["10.1016/j.jep.2014.01.012", "24462785"]}, {"Citation": "Nkambo W., Anyama N. G., Onegi B. In vivo hypoglycemic effect of methanolic fruit extract of Momordica charantia L. African Health Sciences. 2014;13(4, article 933) doi: 10.4314/ahs.v13i4.11.", "ArticleIdList": ["10.4314/ahs.v13i4.11", "PMC4056504", "24940315"]}, {"Citation": "Jia S., Shen M., Zhang F., Xie J. Recent advances in Momordica charantia: functional components and biological activities. International Journal of Molecular Sciences. 2017;18(12):p. 2555. doi: 10.3390/ijms18122555.", "ArticleIdList": ["10.3390/ijms18122555", "PMC5751158", "29182587"]}, {"Citation": "Fuangchan A., Sonthisombat P., Seubnukarn T., et al. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. Journal of Ethnopharmacology. 2011;134(2):422\u2013428. doi: 10.1016/j.jep.2010.12.045.", "ArticleIdList": ["10.1016/j.jep.2010.12.045", "21211558"]}, {"Citation": "Vats V., Yadav S. P., Grover J. K. Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats. Journal of Ethnopharmacology. 2004;90(1):155\u2013160. doi: 10.1016/j.jep.2003.09.034.", "ArticleIdList": ["10.1016/j.jep.2003.09.034", "14698524"]}, {"Citation": "Suanarunsawat T., Na Ayutthaya W. D., Songsak T., Thirawarapan S., Poungshompoo S. Antioxidant activity and lipid-lowering effect of essential oils extracted from Ocimum sanctum L. leaves in rats fed with a high cholesterol diet. Journal of Clinical Biochemistry and Nutrition. 2010;46 doi: 10.3164/jcbn.09-52.", "ArticleIdList": ["10.3164/jcbn.09-52", "PMC2803133", "20104265"]}, {"Citation": "Pattanayak P., Behera P., Das D., Panda S. Ocimum sanctum Linn. A reservoir plant for therapeutic applications: an overview. Pharmacognosy Reviews. 2010;4(7):95\u2013105. doi: 10.4103/0973-7847.65323.", "ArticleIdList": ["10.4103/0973-7847.65323", "PMC3249909", "22228948"]}, {"Citation": "Agrawal P., Rai V., Singh R. B. Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. International Journal of Clinical Pharmacology and Therapeutics. 1996;34:406\u2013409.", "ArticleIdList": ["8880292"]}, {"Citation": "Satapathy S., Das N., Bandyopadhyay D., Mahapatra S. C., Sahu D. S., Meda M. Effect of Tulsi (Ocimum sanctum Linn.) supplementation on metabolic parameters and liver enzymes in young overweight and obese subjects. Indian Journal of Clinical Biochemistry. 2017;32(3):357\u2013363. doi: 10.1007/s12291-016-0615-4.", "ArticleIdList": ["10.1007/s12291-016-0615-4", "PMC5539010", "28811698"]}, {"Citation": "Xiang Y. Z., Shang H. C., Gao X. M., Zhang B. L. A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytotherapy Research. 2008;22(7):851\u2013858. doi: 10.1002/ptr.2384.", "ArticleIdList": ["10.1002/ptr.2384", "18567057"]}, {"Citation": "Kim H. G., Yoo S. R., Park H. J., et al. Antioxidant effects of Panax ginseng C.A. Meyer in healthy subjects: a randomized, placebo-controlled clinical trial. Food and Chemical Toxicology. 2011;49(9):2229\u20132235. doi: 10.1016/j.fct.2011.06.020.", "ArticleIdList": ["10.1016/j.fct.2011.06.020", "21699953"]}, {"Citation": "Shergis J. L., Zhang A. L., Zhou W., Xue C. C. Panax ginseng in randomised controlled trials: a systematic review. Phytotherapy Research. 2013;27(7):949\u2013965. doi: 10.1002/ptr.4832.", "ArticleIdList": ["10.1002/ptr.4832", "22969004"]}, {"Citation": "Shishtar E.'., Sievenpiper J. L., Djedovic V., et al. The effect of ginseng (the genus Panax) on glycemic control: a systematic review and meta-analysis of randomized controlled clinical trials. PLoS One. 2014;9(9):p. e107391. doi: 10.1371/journal.pone.0107391.", "ArticleIdList": ["10.1371/journal.pone.0107391", "PMC4180277", "25265315"]}, {"Citation": "Bunawan H., Bunawan S. N., Baharum S. N., Noor N. M. Sauropus androgynus (L.) Merr. induced bronchiolitis obliterans: from botanical studies to toxicology. Evidence-based Complementary and Alternative Medicine. 2015;2015:7. doi: 10.1155/2015/714158.714158", "ArticleIdList": ["10.1155/2015/714158", "PMC4564651", "26413127"]}, {"Citation": "Suparmi S., Fasitasari M., Martosupono M., Mangimbulude J. C. Comparisons of curative effects of chlorophyll from Sauropus androgynus (L) Merr leaf extract and Cu-chlorophyllin on sodium nitrate-induced oxidative stress in rats. Journal of Toxicology. 2016;2016:7. doi: 10.1155/2016/8515089.8515089", "ArticleIdList": ["10.1155/2016/8515089", "PMC5178362", "28053604"]}, {"Citation": "Hokayem M., Blond E., Vidal H., et al. Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients. Diabetes Care. 2013;36(6):1454\u20131461. doi: 10.2337/dc12-1652.", "ArticleIdList": ["10.2337/dc12-1652", "PMC3661802", "23275372"]}, {"Citation": "Balbi M. E., Tonin F. S., Mendes A. M., et al. Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome. 2018;10(1) doi: 10.1186/s13098-018-0318-5.", "ArticleIdList": ["10.1186/s13098-018-0318-5", "PMC5853104", "29568330"]}, {"Citation": "Choi S. W., Ho C. K. Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy? Redox Report. 2018;23(1):1\u201324. doi: 10.1080/13510002.2017.1324381.", "ArticleIdList": ["10.1080/13510002.2017.1324381", "PMC6748682", "28514939"]}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "10", "Day": "22"}, {"Year": "2019", "Month": "12", "Day": "31"}, {"Year": "2020", "Month": "1", "Day": "16"}, {"Year": "2020", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["32148647", "PMC7042557", "10.1155/2020/1356893"]}}], "PubmedBookArticle": []}